CA2193501C - Luminescent lanthanide chelates and methods of use - Google Patents

Luminescent lanthanide chelates and methods of use Download PDF

Info

Publication number
CA2193501C
CA2193501C CA002193501A CA2193501A CA2193501C CA 2193501 C CA2193501 C CA 2193501C CA 002193501 A CA002193501 A CA 002193501A CA 2193501 A CA2193501 A CA 2193501A CA 2193501 C CA2193501 C CA 2193501C
Authority
CA
Canada
Prior art keywords
chelate
lanthanide
donor
acceptor
luminescence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002193501A
Other languages
French (fr)
Other versions
CA2193501A1 (en
Inventor
Paul R. Selvin
John Hearst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of CA2193501A1 publication Critical patent/CA2193501A1/en
Application granted granted Critical
Publication of CA2193501C publication Critical patent/CA2193501C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G01N33/542Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with steric inhibition or signal modification, e.g. fluorescent quenching
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • G01N33/532Production of labelled immunochemicals
    • G01N33/533Production of labelled immunochemicals with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/80Fluorescent dyes, e.g. rhodamine
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/13Tracers or tags

Abstract

The invention provides lanthanide chelates capable of intense luminescence. The celates comprise a lanthanide chelator covalently joined to a coumarinlike or quinolone-like sensitizer. Exemplary sensitzers include 2- or 4-quinolones, 2or 4-coumarins, or derivatives thereof e.g. carbostyril 124 (7-amino-4-methyl-2-quinolone), coumarin 120 (7-amino-4-methyl-2-coumarin), coumarin 124 (7-amino-4-(trifluoromethyl)-2-coumarin), aminomethyltrimethylpsoralen, etc. The chelates form high affinity complexes with lanthanides, such as terbium or europium, through chelator groups, such as DTPA. The chelates may be coupled to a wide variety of compounds to create specific labels, probes, diagnostic and/or therapeutic reagents, etc. The chelates find particular use in resonance energy transfer between chelate-lanthanide complexes and another luminescent agent, often a fluorescent non-metal based resonance energy acceptor. The methods provide useful information about the structure, conformation, relative location and/or interactions of macromolecules.

Description

2~ 93~~J1 Luminescent Lanthanide Chelates and Methods of Use The research carried out in the subject application was supported in part by grants from the National Institutes of Health and the Office of Energy Research.
The government may have rights in any patent issuing on this application.
INTRODUCTION
Field of the Invention The field of this invention is luminescent lanthanide chelators.
Background Luminescent (including fluorescent and phosphorescent) markers find a wide variety of applications in science, medicine and engineering. In many situations, these markers provide competitive replacements for radiolabels, chromogens, radiation-dense dyes, etc. Improvements in fluorimetric instrumentation have increased attainable sensitivities and permitted quantitative analysis.
Perhaps the single-most significant limitation to the use of luminescent markers is generating an acceptable signal-to-noise ratio. Marker-dependent properties such as absorbtion and emission maxima, Stake's shift, quantum yield, etc. effect the ease of distinguishing signal from auto- or background fluorescence.
Hence, there is a continuous need to provide improved luminescent markers;

especially luminescent markers with long-lived luminescence and/or a large Stokes shifts with long wavelenght emmissions. Other useful and desireable properties include: easy and cost-effective synthesis; chemical stability, especially in an aqueous environment; convenient attachability to a wide variety of macromolecules including proteins and nucleic acids; efficient excitability by a convenient laser;
capable of intense luminescence; the capacity to perform as good luminescent resonance-energy transfer donors, enabling the determination of molecular distances beyond 100A; and usefulness as radiation-hardened ftuorophores in X-ray microscopy.
Relevant Literature Relevant patents include US Patent Nos 4,637,988 (1987) and 4,837,169 (1989).
DTPA-pAS-Tb is reported in Bailey et al. (1984) Analyst 109, 1449-1450.
For background papers on other lanthanide chelators, see Diamandis (1992) Analyst 117, 1879-1884, Canfi et al. (1989) Analyst 114, 1405-1406, Ando et al.
(1993) Biochimica et Biophysics Acta. 1102, 186-194, Georges and Ghazarian (1993) Analytica Chimica Acta, 276, 401-409, Mathis et al. (1993) Clin. Chem, 39, 1953 and Desai et al. '(1993) J. Am. Chem. Soc. 115, 11032, Seveus et al.
(1992) 13, 329-338, Saavedra and Picozza (1989) Analyst 114, 835-838, von Brenndorff et al. (1993) in Proceedings, 4th Intnl Conf on X-ray Microscopy, Chernogolovoka, Moscow District, Russia, Clark et al. (1993) Analytical Biochemistry 210, 1-6.
For an up-to-date review of Fluorescent Resonance Energy Transfer, see, Selvin (1994) Fluorescence Resonance Energy Transfer, in Biochemical Spectroscopy, a volume~of Methods in Enzymology, Academic Press, Ed. Kenneth Sauer, in press (copy attached).
SUMMARY OF THE INVENTION
The invention provides lanthanide chelates comprising a lanthanide chelator covalently joined to a polynuclear heterocyclic aromatic sensitizer of the general formula:
where X comprises an atom from periodic group 5 or 6. A single position 2-8 carbon atom of the sensitizer may be substituted with a linking group through which the sensitizer is covalently joined to the chelator.
This invention also provides a method of enhancing the luminescence of a lanthanide, the method comprising: forming a mixture of a lanthanide chelate as described above and a lanthanide capable of binding the chelate with an equilibrium constant of at least 109 M-1, whereby a luminescent lanthanide chelate-lanthanide complex is formed.
This invention also provides a method of detecting an analyte which may be present in a portion of a sample by luminescence, the method comprising the steps of:
contacting a sample portion with a luminescent complex of the above-described lanthanide chelate and a lanthanide capable of binding the chelate with an equilibrium constant of at least 109 M-1, wherein the chelate is covalently joined to a reagent capable of selectively binding the analyte;
2 0 incubating the sample portion under conditions wherein the reagent is capable of selectively binding the analyte;
exposing the sample portion to light at a first wavelength capable of inducing a first electronic transition in the chelate;
detecting an emission of light from the sample portion at a second wavelength wherein 2 5 the second wavelength is longer than the first wavelength and results from a second electronic transition in the chelate; ' wherein the detection of the emission of light correlates with the presence of the analyte sample protein.
This invention also provides a method of detecting the distance between a first 3 0 position and a second position in a portion of a sample by resonance energy transfer using a luminescent lanthanide chelate donor and an organic resonance energy acceptor, the method comprising the steps of:

3a exposing a sample portion comprising the donor located at the first position and the acceptor located at the second pos ition to light at a first wavelength capable of inducing a first electronic transition in the donor, wherein the donor comprises a complex of a lanthanide chelate as described above and a lanthanide capable of binding the chelate with an equilibrium constant of at least 109 M:-1, and wherein the spectral overlap of the donor emission and acceptor absorption is sufficient to enable energy transfer from the donor to the acceptor as measured by detectable quenching of donor luminescence intensity or lifetime or detectable 1 o increase in acceptor luminescence intensity or lifetime;
detecting at least one of:
the intensity of a first emission of light from the sample portion at a second wavelength, wherein the second wavelength is longer than the first wavelength and results from a second electronic transition in the donor, wherein the intensity of the first emission of light inversely correlates with the distance between the first and second positions of the sample portion; and the intensity of a second emission of light from the sample portion at a third wavelength, wherein the third wavelength is longer than the first wavelength and results from an electronic transition in the acceptor, wherein the intensity of the second emission of light 2 o correlates with the distance between the first and second positions of the sample portion.
In preferred chelates, the sensitizes has a first position 2-8 carbon atom substituted with an oxygen atom through a double covalent bond, a second position 2-8 carbon atom, different than the first position 2-8 carbon atom, substituted with a linking group through which the sensitizes is covalently joined to the chelator, and a substituted third position 2-8 carbon atom, different from the first and second position 2-8 carbon atoms. Frequently, the first position 2-8 carbon atom is the position 2 or 4 carbon atom, the second carbon atom is the position 7 carbon atom, the sensitizes and cheiator are linked through an amine or carboxyl group, and/or the third position 2-8 carbon atom is the position 4 carbon and is substituted with a hydrocarbon or halogen substituted hydrocarbon. Exemplary sensitizers include or 4-quinolones, 2- or 4- coumarins, or derivatives thereof e.g. carbostyril 124 (7-amino-4-methyl-2-quinolone), coumarin 120 (7-amino-4-methyl-2-coumarin), coumarin~ 124 (7-amino-4=(trifluoromethyl)-2-coumarin), aminomethyltrimethylpsoralen, etc.
The chelates axe capable of forming high affinity complexes with lanthanides, such as terbium or europium, through chelator groups, such as DTPA.
Typically, the chelators comprise a plurality of structurally constrained anionic groups such as carboxylate or phosphonate groups. Solutions of chelate-lanthanide complexes are capable of intense luminescence. The chelates may be coupled to a wide variety of compounds to create specific labels, probes, diagnostic and/or therapeutic reagents, etc.
Chelate-lanthanide complexes are useful as detectable labels in a wide variety of applications. Generally, the methods involve contacting a sample portion with a luminescent complex; exposing the sample portion to light at a first wavelength capable of inducing a first electronic transition in the chelate;
and detecting an emission of light from the sample portion at a second wavelength that is longer than the first wavelength and results from a second electronic transition in the chelate. Specific analytes in the sample may be detected by coupling the chelate to a reagent capable of analyte selectively binding.
The chelates also find use in resonance energy transfer between chelate-lanthanide complexes and another luminescent agent, often a fluorescent non-metal 5 based resonance energy acceptor. For example, by coupling the chelate-lanthanide complex donor to one atom and the acceptor to a second atom, the distance between two atoms can be measured. Generally, the spectral overlap of the donor emission and acceptor absorption is sufficient to enable energy transfer from donor to acceptor as measured by detectable quenching of donor luminescence intensity of lifetime or detectable increase in acceptor luminescence.
Where the atoms are on the same molecule, the methods provide useful information about the structure or conformation of the molecule. For example, the methods are used to monitor the status of a polymerase chain reaction by coupling the donor and acceptor to separated atoms of a diagnostic oligonucleotide. As the concentration of target DNA increases, the percentage of diagnostic oligonucleotides hybridized to target DNA increases which in turn increases the mean distance between the labelled atoms. This increased mean distance is detected as a decrease in energy transfer between the donor and acceptor.
Where the atoms are on different molecules, the methods provide useful information on the interactions or relative locations of the two molecules.
DESCRIPTION OF SPECIFIC EMBODIMENTS
We have synthesized a series of new chemical compounds which bind to lanthanide elements including terbium and europium, and efficiently sensitize them, i.e. allow them to be excited efficiently and subsequently luminesce efficiently.
The compounds also enable convenient coupling to macromolecules. We call these compounds lanthanide chelates.
The importance of the invention is several-fold: First, our lanthanide chelates can be used as non-isotopic replacements for radioactive labels.
Second, they can be used as alternatives to conventional fluorescent dyes, especially in imaging applications, with the potential for increased contrast. This increasal contrast arises because the lanthanide luminescence is extremely long (0.6-2.3 millisecond). If one 'uses a pulsed excitation source and gated (time-resolved) detection, the intense autofluorescence (background) will decay away, with the labels still emitting. Such autofluorescence currently prevents fluorescent images of many tissue samples. Third, because the chelates are all excited in the same spectral region, two color imaging is possible. Fourth, the lanthanide chelates can be used as extremely efficient donors in luminescent energy transfer analyses.
This use enables measurements of distances beyond 100A, distances currently not measurable with standard fluorescence energy transfer techniques, but of importance in structural biology and medicine.
Our chelates have a number of important advantages: 1. They are easy to synthesize and attach to macromolecules; 2. They are efficiently excited by a nitrogen laser (at 33~nm); 3. Some of of them (e.g. DTPA-cs124) can sensitize W096/00901 ~ ~ ~ } ~ ~ ~ PCTIU595I08319 both terbium and europium; 4. The lanthanide luminescence from the chelates are extremely intense; for example, the terbium chelate exemplified below luminesces approximately sixty-five times more intensely than DTPA-paraaminosalycilate (DTPA-pAS) when excited at 337 nm; 5. They are chemically stable; 6. They can be used to label nucleic acids and proteins under chemical conditions used in automated synthesizers (e.g. creating phosphoramidites in DNA/RNA technology or protein technology); 7. They are extremely good resonance energy transfer donors. An important element in the success of our chelates in energy-transfer is the fact that there is very little spectral or temporal overlap between the sensitizer's emission and the lanthanide's emission. In contrast, DTPA-pAS has very significant temporal and spectral overlap and provides a poor energy transfer donor; and, 8. They are useful as radiation-hardened fluorophores in X-ray microscopy.
Our lanthanide chelates comprise a polynuclear heterocyclic aromatic sensitizer of the general formula:
~. vxJ
where X comprises an atom from periodic group 5 or 6.
Suitable sensitizers may include a variety of additional structure including structures where the above general formula comprises a structurally minor portion of the sensitizer. Generally, at least one of the position 2-8 carbon atoms, preferably position 2 or 4, is oxidized, preferably to a carbonyl (i.e. double bonded to an oxygen atom). Positions are conventionally numbered: counter-clockwise from the heteroatom which is position number 1. Frequently, another posirion 2-carbon atom, preferably the other 2 or 4 position, is substituted (i.e. a hydrogen atom is replaced) with a group comprising an alkyl, vinyl, oxy (including hydroxyl, alkoxy, carboxyl), carbonyl or substituted nitrogen (e.g. nitro-, amino including substituted amines, etc.), cyano, acetate, etc. group, or a derivative thereof, particularly halide derivatives. Exemplary sensitizers include rhodamine 560, 575 and 590, fluoresceins, 2- or 4.-qainolones, 2- or 4- coumarins, or WO 9blD0901 ~ ~ ~ ~ ~ U ~ PCTIIfS95lidR319 derivatives thereof e.g. coumarin 445, 450, 49U, 500 and 503, 4-trifluoromethylcoumarin (T'FC), 7-diethyl-amino-cumarin-3-carbohydrizide, etc., and especially carbostyril 124 (7-amino-4-methyl-2-quinolone), coumarin 120 (7-amino-4-methyl-2-coumarin), coumarin 124 (7-amino-4-(trifluoromethyl)-2-coumarin), aminomethyltrimethylpsoralen:
15 ~~
~paslBon 1 position A wide variety of derivatives of the above general formula may be used as sensitizers, so long as the resultant chelate provides the requisite lanthanide binding and luminescence enhancement. By enhanced luminescence is meant that a solution of the chelate complexed with a lanthanide, when exposed to light at a wavelength, the complexed lanthanide emits light of greater intensity or lifetime WO 9b100901 ~ 1 9 ~ J ~ ~ PCTlUS95108319 than an identical sample absent the chelate. The enchancemcnt is usually at least 503&, preferably at least 500%, mare preferably at least 5000%, most preferably at least 50,000 greater intensity under at least one set of conditions (e.g.
specified concentration, solvent system, etc.) e.g. see conditions described herein.
To effectively excite the resident lanthanide, the chelates generally provide absorbtion maxima between 150 and 750 nm, usually between 200 and 650 nm, more usually between 250 and 550 nm, most usually between 300 and 450 nm.
Generally, detected emissions are at least 50 nm, usually at least 100 nm, more usually at least 150 nm greater than the incident light. For example, preferred detected emissions for terbium and europium are 492 and 546 nm and 617 and 695 nm, respectively. Extinction coefficients generally exceed 5,000, usually $,000, more usually 11,000.
The selection of particular chelator-sensitizer combinations is dependent on the intended application. Criteria include the selected lanthanide, sources of potential background fluoresence, quenching agents, the incident light source, etc.
Functionally, suitable chelates for a given lanthanide are identified by coupling a candidate sensitizer to a chelator such as DTPA, complexing with the lanthanide, and identifying complexes capable of enhanced lanthanide luminescent. Assay details are described below.
The chelates are capable of forming high affanity complexes with lanihanides, such as terbium or europium. The chelates bind at least one lanthanide, preferably at least one of terbium and europium, with an equilibrium constant of at least 106 M'', preferably at least 10g hl-', more preferably at least 10'° Ma under at least one set of conditions described herein. A wide variety of structural moieties can be used to provide the requisite lanthanide binding affinity, so long as the resultant chelate provides the requisite luminescence. However, the lanthanide is usually ionically bound by anionic groups such as carboxylate or phosphonate groups.
Frequently, the chelates comprise one or more structurally distinct chelator portions. Typically, these chelator portions comprise a plurality of structurally constrained anionic groups such as carboxylate or phosphonate groups. In a preferred embodiment, these portions are selected from compounds which themselves are capable of functioning as lanthanide cheIators with the W096/n09d1 { ~ ~ PCTlUS95108319 aforementioned binding affinities. For example, such chelator portions include EDTA, DTPA, DOTA, N'I'A, HDTA, etc. and their phosphonate analogs such as DTPP, EDTP, HDTP, NTP, etc. The chelate's lanthanide affinity may also be a cooperative (synergistic) result of the interaction of a plurality of functional groups.
S Far example, one ar more amino acids moieties, e.g. glycine, of the chelate can be structurally positioned to bind vacant coordination sites of the lanthanide to enhance overall binding affinity.
Where the cheIate comprises a structurally distinct chelator portion, it is usually cavalently joined to the sensitizes portion, typically through a linking 10 group. Any linking group thak is capable of cavalently Linking the sensitizes with the chelator and does not preclude requisite lanthanide binding and luminescence may be used. Thus, the linking group may comprise a wide variety of structures.
Frequently, the linking group comprises a nitrogen, carboxyl, carbonyl or alcohol group or a nitrogen or carboxyl derivative and is covalently joined to a position 2-8 carbon atom in the general formula. The linking group is often covalently joined to one of the position 2-8, frequently position 7, carbon atoms above. Common linking groups are aliphatic and aromatic amines, which may be primary or secondary, carboxyls and suIfhydryls. The chelator and sensitizes are frequently joined through an amide, anhydride, disulfide, thin-urea, thioether, etc.
band.
The chelates may be synthesized in any convenient way. Many of the disclosed sensitizers and chelators sensitizers are commercially available -others are synthesized or modifed from commercial starting materials according to conventional methods. The two may be coupled by any convenient chemistry, though they are most often directly coupled through functional groups as described herein. For example, same of the preferred chelates are based on a ruction between an anhydride (e.g. of diethylenetriaminepentaacetic acid, caDTPA) and a sensitizes (the DTPA acts as the chelator, binding the lanthanide tightly and preventing radiationless deactivation by water, and the organic compound acts as a sensitizes, allowing efficient excitation of the lanthanide). These chelates may be made by a modification of the procedure of Bailey et al (1984) Analyst 109, .1449-1450, where an amine-containing sensitizers replace pAS. The anhydride of DTPA
are separately dissolved in an anhydrous organic solvent, typically dry dimethylsulfoxide. The anhydride and selected sensitizes are then mixed and 21 ~~'~v ~
WO 96/00901 PCTlUS95108319 allowed to react for approximately an hour. The anhydride reacts with the amine on the sensitizes to form a stable amide bond.
Where desired, the chelate may be coupled to an analyte-specific reagent, organic polymer, macromolecule (esp, biomolecules like nucleic acids and proteins), etc in any convenient way. For example, for covalent coupling to a protein (or other amine containing macromolecule), the chelate can be originally formed using the dianhydride of DTPA. After coupling to the sensitizes, the mixture is then added to the amine-containing macromolecule, either in an organic solvent or in an aqueous solvent. The second dianhydride then reacts with the amines) on the macromolecule, forming another amide bond. The reactivity of the amine is sufficiently great that this reaction can be done in an aqueous medium (even though water competes for reaction with the anhydride).
Alternatively, a bifunctional linker can be used to couple the chelate and the macromolecule. For example, a suitable linker may comprise both a thiol reactive group (e.g. maleinide, acetyl halide, etc.) and an amine reactive group (e.g.
thiourea, isothiocyanate, etc.). For instance, the mono-anhydride of DTPA may be coupled to a protein by reacting with 3-(2-pyridyldithio)propionyl hydrazide (PDPH).
Chelate-lanthanide complexes are useful as detectable labels in a wide variety of applications. Generally, the methods involve contacting a sample portion with a luminescent complex of a chelate and a lanthanide; exposing the sample portion to light at a first wavelength capable of inducing a first electronic transition in the chelate; and detecting, advantageously with a time delay to minimisze the detection of shorter-lived background luminescence, an emission of light from the sample portion at a second wavelength that is longer than the first wavelength and results from a second electronic transition in the chelate.
Specific anaIytes in the sample may be detected by coupling the chelate to a reagent capable of analyte selectively binding.
The methods are adaptable to a wide variety of samples including biological samples and extracts (such as physiological fluids, nucleic acid and/or proteinaceous solutions, microbial cultures, ete.), environmental samples (such as water sources), industrial, especially chemical reagents, products and wastes, etc.
The chelates may be free in solution or restrained in a variety of ways. For WO ~6I00901 ~ ~ ~ ~ ~ ~ ~ PCTIUS95I08319 IL
example, the chelates may be preferentially partitioned in or on one phase, solid or liquid, such as adsorbed onto a solid surface or membrane or retained within a bead (e.g. latex microspheres). Thus, the methods are useful in conjunction with sorting (e.g. cell sorting), chromatography, electrophoretic, osmotic and centrifugal separations. Heat and organo-stable chelates are selected for applications involving elevated temperature (e.g. distillations, combustions, etc.) and organic extractions.
The first wavelength (that of the incident light) is selected to optimize the ultimate signal-to-noise ratio of the lanthanide emission. Frequently, fhe incident light is provided in a form to minimize background absorption. Useful sources include lasers (e.g. nitrogen, helium-cadmium, dye lasers, etc.) and arc lamps (e.g.
high-pressure, mercury, xenon, quartz, etc.). Nitrogen lasers are particularly preferred because their 337 nm emission frequency is close to a lanthanide absorbtion maximum. Similarly, the second wavelength is selected to optimize signal-to-noise ratio and in view of the available instrumentation.
The subject chelates may be coupled to a wide variety of compounds to create specific labels, probes, diagnostic andlor therapeutic reagents, etc.
Examples include biomolecules such as proteins (antibodies, enzymes, receptors, etc.), nucleic acids (RNA, DNA, etc.), bioactive molecules (drugs, toxins, etc.);
solid subtrates such as glass or polymeric beads, sheets, fibers, membranes (e. g.
nylon, nitrocellulose), slides (e. g. glass, quartz) and probes; etc.
Many of our chelates are particularly amenable to what we term Luminescence Resonance Energy Transfer, or LRET. LRFT is a generalized version of Fluorescent Resonance Energy Transfer, or FRET, a widely used technique in polymer science, biochemistry and structural biology. FRET can be used to measure the distances between two points that are labelled with fluorescent dyes and separated by approximately 10-75A. The technique is valuable because measurements can be made under physiological (or other) conditions with near-Angstrom resolution and with the exquisite sensitivity of fluorescence measurements. FRET relies on a distant-dependent transfer of energy from one fluorescent dye -- the donor - to another absorbing or fluorescent dye -- the acceptor. The donor and acceptor are site-specifically placed at the two points that one wishes to measure the distance between.

~1 '~:~~~~~
WO 96100901 PCTIUS95lD8319 While lanthanides do not fluoresce, the use of our chelates permits them to be efficiently excited. A non-fluorescent quantum transition of the lanthandide can then effect a non-radiative energy transfer to a suitable and appropriately distanced acceptor. To effect transfer, an acceptor absorbtion must overlap a lanthanide emission. The chelate - acceptor pair is selected for optimal overlap: for longer distance measurements, greater overlap is preferred. Since the lanthanides have lifetimes on the order of a millisecond, the signal-to-noise ratio of sensitized emission of the acceptor in LRET is improved by emission detection through time resolution (pulse delay) or phase modulation. Energy transfer can be detected by donor quenching or, preferably acceptor luminescence.
By using luminescent lanthanide chelators as donors (instead of conventional dyes), and conventional fluorescent dyes as acceptors, we have improved the signal to background of LRET by approximately 100-fold. This improvement allows measurements beyond 100A, a distance currently unmeasurable using small, conventional fluorescent dyes. This distance regime is important in many biological problems. Using lanthanide chelators as donors also makes distance measurements more accurate, because the chelators minimize the uncertainty in the orientation-dependence of energy transfer. We have also demonstrated the first lifetime measurement of the sensitized emission of the acceptor, a LRET
measurement which eliminates problems associated with non-specific or incomplete labelling.
A wide variety of acceptors are useful with our chelate donors. Generally, the selected acceptor will have an absorbance maximum at a wavelength between nm and 250 nm longer than that of the donor chelate. Exemplary acceptors 25 include xanthene dyes such as fluoresceins and rhodamines, coumarins, benzimide dyes, phenanthridine dyes, ethidium dyes, acridine dyes, cyanine dyes such as thiazole orange, thiazole blue, CyS, Cy5.5, Cy3, etc., carbazole dyes, phenoxazine dyes, porphyrin dyes, quinolone dyes, pycobillyc proteins, e.g.
allophycocyanin, R-phycoerythrin, B-phycoerythrin, Bodipy dyes, etc. The acceptors generally emit in the visible or infrared ranges.
LRET is particularly useful to obtain structural and kinetic information about macromolecules in solution, in real time. For example, double-end labeled oligonucleotides provide detectable LRET signalling when hound by nucleic acid .,~~,;
wo 9sroovat ~ 1 ~ J ~ a i ~'~S9srox3m binding proteins, e.g. transcription factors. Accordingly, the methods are used to screen for potential therapeutics that alter the structure or interactions of biomolecules; far example, anti-viral agents are sceened far the ability to alter viral transcription factor-induced alterations in nucleic acid conformation.
The general LRET-based method of detecting the distance between a first position and a second position in a portion of a sample involves: exposing a sample portion comprising the donor lanthanide-chelate complex located at the first position and the acceptor located at the second position to Tight at a first wavelength capable of inducing a first electronic transition in the danar. The spectral overlap of the donor emission and acceptor absorption is sufficient to enable energy transfer from the donor to the acceptor as measured by detestable quenching of donor luminescence intensity or lifetime or detectable increase in acceptor luminescence intensity or lifetime. Then the intensity of a first emission of light from the sample portion at a second wavelength is detected wherein the second wavelength is longer than the first wavelength and results from a second electronic transition in the donor, wherein the intensity of the first emission of light correlates with the distance between the first and second posifions. In other words, the closer the positions, the greater the energy transfer and the greater the donor quenching. Alternatively, one can detect the intensity of a second emission of light from sample partian at a third wavelength, wherein the third wavelength is longer than the first wavelength and results from an electronic transition in the acceptor, wherein the intensity of the second emission of light inversely correlates with the distance between the first and second portions of the sample portion. In ether wards, the closer the positions, the greater the energy transfer and the greater the acceptor luminescence.
This general method has broad application whenever the static or dynamic distance between to positions, e.g. two atoms or molecules, is of interest. In one specific embodiment, the method is used to monitor the status of a polymerase chain reaction. Here, the sample portion comprises a target nucleic acid strand comprising a first strand portion and a diagnostic nucleic acid strand labeled proximal to one end with the acceptor and proximal to' the other end with the donor (i.e. comprising a first atom covalently joined to the donor and a second atom covalently joined to the acceptor, the first and second atoms being separated by a WO 96!00901 ~ J PCTlUS95108319 second strand portion). The first and second strand portions are sufficiently complementary to hybridize under annealing conditions, and the second strand portion is of sufficient length to provide a detectable difference in the aggregate energy transfer from the donor to the acceptor when the first and second strand 5 portions are hybridized as compared with the aggregate energy transfer from the donor to the acceptor when the fast and second strand portions are not hybridized.
The detectable difference is measured as at least one of a detectable quenching of donor luminescence or detectable increase in acceptor luminescence, and the distance between the first and second atoms indicates whether the nucleic acid 10 strands have hybridized. Thus, as the reaction proceeds, the stepwise increase in the amount of target nucleic acid is reflected in a stepwise decrease in energy transfer.
The following examples are offered by way of illustration and not by way of limitation.
EXAMPLES
Example 1.
In this example, we exemplify the technique of luminescent resonance energy transfer (LRET) by introducing a luminescent teibium chelate as a donor, and an organic dye, tetramethylrhodamine, as acceptor. The results are consistent with a Forster theory of energy transfer, provided the appropriate parameters are used. The use of lanthanide donors, in general, and this pair, in particular, has many advantages over more conventional FRET pairs which rely solely on organic dyes. The distance at which SOgo energy transfer occurs (Ro) is large, 65A;
the donor lifetime is single exponential and long (millisecond), making lifetime measurements facile and accurate; uncertainty in the orientation factor (rc2) which creates uncertainty in measured distances is minimized by the donor's multiple electronic transitions and long lifetime; the sensitized emission of the acceptor can be measured with little or no interfering background, yielding a > 25 fold improvement in signal to background over standard donor-acceptor pairs. These improvements are expected to make distances greater than 100A measurable via LRET. We also report measurement of the sensitized emission lifetime, a L i '~ :.~ ~a WO )6/00901 PCrlU5951p8319 measurement which is completely insensitive to total concentration and incomplete labeling.
In FRET a fluorescent donor molecule transfers energy via a non-radiative dipole-dipole interaction to an acceptor molecule (which is usually a fluorescent molecule). FRET is a standard spectroscopic technique for measuring distances in the 10-70A range. Upon energy transfer, which depends ort the R~ distance between the donor and acceptor, the donor's lifetime and quantum yield are reduced, and the acceptor fluorescence is increased, or sensitized(1). FRET is frequently used in both polymer science and structural biology and has recently been used to study macromolecular complexes of DNA, RNA, and proteins (2-4).
Despite these successes, FRET has had a number of serious flaws which has limited its utility. First, the maximum distance which can be measured has been less than optimal far many biological applications. Second the lifetime of commonly used donor fluoraphores are short (typically a few nanoseconds) and multiexponentiai, making lifetime measurements difficult and of limited accuracy.
Third, the signal-to-background of the sensitized emission has been law due to interfering iluarescencx from the donor and from direct excitation of the acceptor.
Fourth, precise distances have been difficult to determine because the efficiency of energy transfer depends not only on the R-6 distance between the donor and acceptors, but also on their relative orientation, as expressed by the x2 factor. (The efficiency of energy transfer = I!(I+R°!Ro ), where Rpis a function of rr~ aee Appendix).
The luminescent lanthanide elements terbium and europium are attractive FRET donors because they potentially overcome many of these problems. Because lanthanide emission does not arise from a singlet to singlet transition, energy transfer using lanthanide donors is more accurately called luminescence resonance energy transfer (LRET:). The lanthanides have primarily been used in diffusion-enhanced FRET (5) and as isomarphous replacements in calcium-binding proteins (6-8). In addition, it~athis has used europium cryptates with the multichramophoric Allophycocanin to achieve an extremely large Ro of 90A (9). We have recently presented results showing numerous advantages of using a palycarboxylate-chelate of europium as a donor in conjunction with an organic dye such as CY-5 as the acceptor (10). Here we extend these results to the use of terbium as a donor.

~' 1 ~3 :~ ~ ;~F ~
WO 9G/0(1901 PC'flUS95108319 As a model system, we covalently attach donor and acceptor to the 5' ends of a series of double-stranded DNA oligomers of varying length. The use of DNA
in such a model system has been previously shown to be valid for energy transfer measurements between organic dyes (11).
Material and Methods Synthesis of Labeled DNA Oligomers. Complementary DNAs of 10,12,14 bases in length were synthesized using standard phosphoramidite procedures. An amino-group attached via a six-carbon linker (Glen Research) was incorporated at the 5' end. The acceptor sequence wasp that used by Clegg et al (11): 5'-CCA-CTC-TAG-G-3' (lObp); 5'-CCA-CTG-GCT-AGG-3' (l2bp); 5'-CCA-CTG-CTG-CTA-GG-3' (l4bp). The 5-isomer of Tetramethylrhodamine-isothiocyanate (Molecular Probes. T-1480: abbreviation: TMR) was attached via standard procedures and purifred by reverse phase HPLC. Extinction coefficients for TMR
attached to DNA were determined to be el~,= 33mM-'crrt' and else=93mh1'crri'.
The donor-strand consisted of complementary DNA labeled at the 5' end with a terbium chelate. The chelate is diethylenetriaminepentaacetic acid coupled to a laser dye, carbostyril 124 (DTPA-cs124). Details of the donor chelate synthesis will be presented elsewhere. Unlabelled DNA oligamers were also synthesized.
I3ybridization Conditions: Donor and acceptor strands were mixed in desired ratio in a DSO-based buffer containing lOmM Tris, pH 8.0, lOmM MgCI~, 150mM NaCI. Experiments were also performed in an Hz0-based buffer. Donor strand concentration was approximately 200nM. Oligomers were annealed by heating to 75°C and cooled to the final temperature (22°C or 5°C) over 15 minutes.
Spectroscopy: Absorption measurements were made on a Hewlett Packard 8452A spectrometer. Steady-state fluorescence measurements were on a SPEX
Fluorolog fluorimeter. Time-resolved and gated luminescence measurements were made on a laboratory-built spectrometer utilizing right-angle detection with a pulsed Laser-Photanics Nitrogen laser (Snsec pulse width, 40Hz repetition rate), a Gallium-arsenide photon-counting detecaor, a gated discriminator (Ortec 584) and a multichannel scalar with 2 sec time-resolution. Polarization studies were also conducted although energy-transfer experiments performed without an analyzer W096/UU9U1 ~ f '~ J ~ U ~ PCT/US95/U8319 is gave the same results as those using an analyzer. An analyzer was therefore routinely omitted. A temperature-regulated cuvette-holder and a quartz 3mmx3mm cuvette was used. Lifetime data was fit using TableCurve software (Jandel Scientific).
Results and Discussion The structure of the donor chelate, DTPA-cs124-Tb, and the model system used for energy transfer is shown below:
~+
(~3;~, ~vCt72-P-C C T~~~ T G
3'-GGA~~~AC
The donor-chelate has several important features. First, the chelate binds terbium (and europium) extremely tightly - titration with a 100 Fold excess of EDTA (Kb < 10")~'') is unable to displace a measurable amount of terbium. This is in agreement with ocher DTPA-based chelators (12) and ensures that there is no free terbium. Second, the chelate allows site-specitic attachment of terbium to macromolecules. Third, the chelate shields the terbium from non-radiative deexcitation mechanisms, likely resulting in a quantum yield for terbium luminescence near unity in D20 (see Appendix I). Finally, the covalent attachment WO 96!00901 ~ ~j 1 PCT1US95/OS319 of the laser dye carbostyril 124 overcomes the extremely low absorption cross-section of terbium (< 1 M~'cm') (6). The cs124 absorbs light (e32g=11,000 M-'crri '; Eg3g= 8,000 M-'crri') and because of its close proximity to the terbium, transfers energy to the lanthanide (13, 14).
Figure 1 shows the spectral characteristics of the terbium chelate and the tetramethylrhodamine which lead to efficient energy transfer and a large Ro of in D20 (60 A in HBO). Ro is calculated from standard equations (see appendix).
Here we mention two unusual aspects of using a lanthanide chelate as donor: 1) The efficiency of energy transfer can be adjusted, and hence Ra optimized for the particular system being measured, simply by varying, the ratio of Hx0 to Dz0 in the solvent. The H20/Dz0 ratio affects the efficiency of energy transfer by altering the lanthanide quantum yield (q") in our chelate (q,~~ 1 in DSO;
q"~0.6 in HZO; see Appendix 1) (15). 2) The orientation dependence of the energy transfer process is minimized because the terbium has multiple, degenerate, electronic transitions and is therefore an isotropic donor, even if stationary. This minimizes uncertainty in the measured distance due to orientation effects of +/-12% in the worst case(16).
Figure 1 also shows the highly spiked nature of the terbium emission.
Donor quenching can be measured without interference From acceptor emission at 492nm and 546nm. Similarly, the sensitized emission of the acceptor can be measured without significant interferencz from donor luminescence because terbium is nearly silent around 570nm, where TMR is at 70% of its emission maximum. The terbium signal at 570nm is 240x less than at its maximum, 546nm.
When measuring the sensitized emission, we can also eliminate the direct fluorescence of the acceptor by temporal discrimination. We use pulsed excitation, and collect data only after a 90 wsec delay, during which time direct fluorescence of the rhodamine has decayed away. (The acceptor fluorescence, with a lifetime of a few nanoseconds, decays rapidly; we also find a small component - probably either delayed fluorescence or a detector artifact - which decays away within the 90 .sec delay.) The donor, because of its millisecond lifetime, stays excited and capable of transferring energy at the end of the delay period. Consequently, any signal arising around 570nm after the delay is due only to sensitized emission, i.e.
fluorescence of the acceptor due to energy transfer.

2~ 9l~'~' W096100901 .~'.)f.! ~ PCTlUS95/08319 Figure 2A shows the results of an energy transfer experiment on a partially hybridized lOmer DNA. The average energy transfer is 77°k. The signal to background of the sensitized emission at 570nm is 54:1. By comparison, the signal to background for sensitized emission when using fiuorescein-rhodamine as 5 energy transfer pairs on the same DNA is approximately 1. Because the background is so small in our case, small signals become measurable, and hence distances much greater than 12o are expected to be possible. I-Iorrocks and Bruno, for example, have shown the ability to measure distances of 4Ro (lta=3.1A) utilizing the dark-background sensitized emission of tyrosine to terbium energy 10 transfer (6).
We can isolate the sensitized emission signal from donor luminescence even in regions where donor luminescence is significant. In a procedure analogous to that used by Clegg et al (11), we can subtract the donor luminescence at all wavelengths, leaving the sensitized emission signal. The efficiency of energy 15 transferred is then simply the area of the corr~ted sensitized emission, divided by the total corrected area:
efficiency of energy transfer = (falqA ) / (fR/q,, t fo) (1) where f" is the area under the sensitized emission curve, q,, is the fluorescence quantum yield of the acceptor, and fp is the area under the donor luminescence 20 cuwe. One can determine the quantum yield of the acceptor by a comparison with the donor quenching data. Based on a quantum yield of 0.174 for TMR (see Appendix I1), equation 1 yields an average energy transfer of 77~.
Figure 2B shows the lifetime data on a series of lOmer DNA oligomers.
The donor-only (single stranded DNA) signal is single exponential with a lifetime of 2.14msec. (A terbium labeled DNA oligomer hybridized to its complement is single exponential with a lifetime of 2.80m sec. The difference in lifetime between double-stranded and single-stranded terbium-only DNA is likely due to different radiative rates arising from different symmetries surrounding the terbium, rather than different quantum yields.) A titration with increasing amounts of acceptor strand shows bi-exponential donor quenching (curves B and C). The long-lifetime component corresponds to unhybridized, donor-only single stranded DNA; the short component corresponds to those terbium-strands that are hybridized with acceptor strands. As expected, increasing the amount of acceptor strand increases ~~r~, WO 9GI00901 ~ ' ~ ~ "I L , PCT/US95108319 the amplitude of the short component and decreases the amplitude of the long component, while leaving their lifetimes unchanged (compare curves B and C).
That the long-time component equals the donor-only signal is an important internal control which shows that intermolecular energy transfer is not significant.
The lifetime of the short component corresponds to an energy transfer in the donor-acceptor complex of 88% (1-331p,secJ2809psec). By comparison, the energy transfer an the same lOmer DNA with the same six-carbon linkers using fluorescein-TMR pair is 23% (11).
In calculating the efficiency of energy transfer based on the sensitized emission curve, we ignore the short time component since this is due to residual signal arising from the direct fluorescence of the acceptor. (No gate was used for this data). Multiple experiments show the long-time component is repeatable to within 10% in the worst case, and usually repeatable within a few percent. The short-time component, however, is highly variable since there is a very large, very short spike due to direct fluorescence which cannot be resolved.
At two-fold excess of acceptor strand, there is still a 10-12% unhybridized component. A similar phenomenon has been seen with dye-labelled oligomers (17) and in FRET experiments with europium substituted in our chelate (10}. In our case it does not appear to be a simple melting-temperature phenomenon since it is present at both 5°C and 22°C. The reason for this is under investigation. It is unlikely that this residual unquenched donor signal is due to fundamental lanthanide photophysics since this would require an uncoupled magnetic dipole transition, a situation which is not present since all terbium (and europium) luminescence arises from the same excited state (18, 19).
Figure 2B also shaves the lifetime of the sensitized emission at 570nm corresponding to the biexponential donor-quenching (curve B}. The sensitized emission decay can be accurately fit to the equation: y=33%exp(-t/45~sec) +
67%exp(-tJ326tcsec). The 45msec component corresponds to direct fluorescence from the acceptor or a detector artifact (which can be eliminated by gating}.
The 326usec component is due to energy transfer on the donor-acceptor complex, and agrees extremely well with the 329-331~csec donor quenching component. Note that after approximately 90 uses, the only species which contribute to the sensitized emission signal is the donor-acceptor complex - donor-only or acceptor-only do ~ ~ PCTIU595I08319 WO 9b1110901 not contibute. This significantly minimizes the problem of incomplete labeling.
The sensitized-emission lifetime signal is also insensitive to total concentration, to quantum yields, and to non-energy-transfer effects which can cause donor quenching.
Table 1 summarizes the lifetime and energy transfer data on donor-acceptor labelled DNA duplexes of 10,12, and l4bp length.
Table I
Lifetime Efficiency of Calculated Clegg et al.
(psec) energy transfer Distance (A) Distance (A) IOmer 336 0.88 46.6 55.5 l2mer 724 0.74 54.6 56.4 l4mer 1154 0.59 b1.2 61.0 Data. from multiple experiments show donor quenching and sensitized emission lifetimes for a given length DNA agree always within 10%, usually within a few percent. As expected, there is a decrease in energy transfer with increasing distances. For comparison we include the distances determined by Glegg et al. using f(uorescein-TMR (11). Both results are consistent with the DNA double-helix geometry, although differing salt conditions and donor-lifetimes lead to different dye positions, and hence different measured distances. We have fit our distances using the Clegg et al. model of the DNA helix and attached dyes.
With only three data points, it is not possible to resolve uniquely all the parameters in the model, but nevertheless, a good fit to their model is achieved if it is assumed that the terbium chelate andfor acceptor are fairly close to the DNA
helix.
This reduces the modulation seen in their FRET data, which arises because of the helical geometry of the DNA and the fact that their donor and acceptor are extended away from the helix (19A and 13A, respectively). This difference is qualitatively reasonable since the long-lifetime of our donor is expected to allow constrained diffusion of the donor and acceptor within the limits placed by the six-r, ~ ,- ~..
I~~J.>~u~
WO 96100901 PCfIUS95108319 carbon linkers, and because of the greater ionic strength used here, which minimizes charge repulsion.
In summary, the data are consistent with the geometry of the double-helix DNA if the energy transfer data are derived based on the dipole-dipole Forster-type mechanism. Numerous technical advantages of luminescence resonance energy transfer make this a technique well suited for measurements on biologically interesting macromolecules.
Appendix I
Calculation of Ro: Ra, the distance at which 50% of the donor's excited state energy is transferred to the acceptc:r, is calculated from standard equations (1}:
Ra = (8.79 x lOv J n2 n'° qU ) "d ~. (2) where q"is the luminescence quantum yield far donor emission fn the absence of IS acceptor, J is the spectral overlap of the. donor emission (fp) and acceptor absorption (eA) (J= f fDea)," dh), n is the index of refraction and kz is a geometric factor related to the relative angles of the tw°o dipoles. Here we evaluate each of the terms in equation 2 and discuss their uncertainty.
The index of refraction, n, varies from 1.33 for water to 1.39 for many organic molecules. We have used 1.33. A numerical integration leads to a J
overlap integral of 3.8x10'Snm'hM. This is an upper limit for J since the 546nm peak of terbium may arise from magnetic dipole, as well as electric dipole transitions (19), and the former do not significantly transfer energy (18}.
The fraction of magnetic dipole contribution can be calculated theoretically (20, 21}, or the problem avoided by using the 492nm line of terbium, which is known to be solely an electric dipole transition (20).
When using organic dyes in FRET, rcz is often a significant source of uncertainty and in the worst case, may vary from 0 to 4 (22). With terbium, however, emission arises from multiple electronic transitions which constrain r,~:l/3< rc2< 4/3. In addition, it is likely that the acceptor can undergo rotational motion during the millisecond donor-lifetime. This further constrains n~ and we assume rcz=2/3, corresponding to a random orientation rotating rapidly within the donor lifetime.

l?'~3~~i 1 The luminescence quantum yield of the terbium, qp, is difficult to accurately determine because of terbium's intrinsically low absorbance. q,~, however, is likely very close to 1 in Di0 (see helow). Note that when calculating Rn, it is important to use the terbium quantum yield (= 1 in Da0), not the S quantum yield of the entire chelate. 'fhe quantum yield of the entire chelate equals the lanthanide quantum yield times the fraction of energy absorbed by the cs124 that is transferred to the lanthanide.
Quantum yield of lanthanide emission: There are several lines of (indirect) evidence which argue qD ~ 1 in DxO. First, emission arises from 4f-4.f inner shell electrons which are shielded from the solvent and other sources of non-radiative deexcitation by the chelate. The 1.2 Hz0 molecules in the primary coordination sphere of the terbium in our chelate (data not shown) are the primary source of non-radiative deexcitation, but these are replaced by D20, which do not significantly deactivate terbium (I5, 23). The nonwater ligands, carboxylate groups and amine nitrogens are extremely inefficient at deactivating the terbium excited state (23). Via temperature studies (24), we have also looked for quenching effects of the cs124 and have found none.
A second line of evidence supporting qp = 1 in Dz0 comes from the work of Elbanowski and coworkers who directly measured the quantum yield of a 1:3 ZO mixture of terbium: EDTA in H20, and found a value of 0.54 (ZS). This measurement is difficult and of unknown accuracy, but nevertheless, it suggests a high quantum yield even in HZO, and the quantum yield in DSO is expected to be considerably higher. (There are probably 2 water molecules coordinated to the terbium in their complex (23)).
The third line of evidence comes from energy transfer experiments using terbium as a donor in thermolysin (8, 26), and as an acceptor in invertebrate calmodulin (6), where the assumption (sometime implicit) of unity quantum yield in DZO gives good agreement with x-ray crystallography data.
Appendix II
Calculating the fluorescence quantum yield of the acceptor: By comparing the donor-quenching lifetime data with the areas and using equation 1 it is possible to measure the quantum yield of the acceptor. This is a general and new method W09B100901 ~ 1 ~ ~ ~ ~ y PCTIUS95t08319 for measuring quantum yields of any dye whose absorption overlaps the emission of terbium (or europium). It has the advantage over more conventional methods of measuring quantum yields in that the measurement involves only one sample -the actual sample of interest - rather than comparing a reference to the sample.
5 T'o evaluate the quantum yield of TMR, we assume the unknown in equation 1 is q,, and take the average efficiency of energy transfer to be 77.6%, as determined from curve C (supra). Based on the integrated areas (620 for f,, and 1032 for f", in arbitrary units), this yields q,, = 0.174. By comparison, free tetramethylrhodamine in phosphate-buffered saline has a quantum yield of 0.25, as 10 measured by standard techniques (27).
Parenthetical references of Example 1.
1) Cantar and Schimmel, (1980) Biophysical Chemistry. (W. H. Freeman and Co., San Francisco}; 2) Clegg, (1992) Methods Enzymol. 211:353-388; 3) Selvin, (1994) Methods En~ymoJ. 246, (in press); 4) Coker et al., (1994) 15 Resonance Energy Transfer. (VCH Publishers, Inc.) (in press); S) Stryer et al., (1982) Annu. Rev, of Biophys. and Bloengin. 11:203-222; 6} Bruno et al., (1992) Biockem. 31:7016-7026; 7) Crance and Horrocks, (1.992) Biochenr. 31:7963-7969;
8) Horrocks, et al., (1975) Proc. Natl. Acad. Sci. USA 72:4764-4768; 9) Mathis, (1993) Clin. Chem. 39:1953-1959; lOj Salvin et al., (1994) JACS (in press);
11) 20 Clegg et al., (1993) Proc. Natl. Acarl. Sci., USA 90:2994-2998; I2) Oser et al., (1990) Anal. Biochemistry 191:295-301: 13) Abusaleh and Meares, (1984) P)rotochem. & Photobiol. 39:763-769; 14) Kirk et al., (1993) J. Phys. Chem.
97:10326-10340; IS) Horrocks et al., (1977) JACS 99:2378-2380; 16} Stryer, (1978) Ann. Rev. Biochent. 47:819-46; 17) Cooper and Hagerman, (1990) 25 Biochemistry 29:9261-9268; 18) Dexter, (1953) J. Chem. Phys. 21:836-850;
19) Bunzli, (1989) Luminescent Probes, ed. Bunzli, 7.-C.G., Choppin, G.R.
(Elsevier, New York), pp. 219-293; 20) Carnall et al., (1968) J. Chen:. Phys. 49:4412-4423;
21) Goriler-Walrand et al., (1991) J. Phys. Chem. 95:3099-3106; 22) Dale et al., (1979) Biophys. J. 26:161-194; 23) Hoirocks and S~sdnick, (1979) J. Am. Chem.
30, Soc. 101:334-350; 24) Alpha et al., (1990) P)totochem. and Photobiol.
52:299-306;
25) Elbanowski et al., (1989) Mnnat. Chem. 120:699-703; 26) Berner et al., (1975) Biochem. do Biophys. Res. Comrntm. 66:763-768; and 27) Waggoner, (1994} Hfethods Enzymol. 246 (in press).

Example 2.
In this example, we exemplify the technique of fluorescence resonance energy transfer (FRET) by introducing a europium chelate as donor and an organic dye, CY-5 as acceptor. The use of lanthanide donors, in general, and this pair, in particular, has many advantages over more conventional FRET pairs which rely solely on organic dyes. The Ro is large, 70A; the donor lifetime is single exponential and long (2.Smsec in D20); the orientation factor which creates uncertainty in measured distances is minimized by the donor's multiple electronic transitions and long lifetime; the sensitized emission of the acceptor can be measured with little or no interfering background, yielding a >50 fold improvement in signal to background over standard donor-acceptor pairs. This improvement in signal to background is expected to make distance measurements of greater than 10011 feasible. We also measure the sensitized emission lifetime, a measurement which is independent of total concentration and incomplete labeling.
We have used a luminescent europium chelate as donor and an organic dye, CY-5 as acceptor. This luminescence resonance energy transfer (F.RET) has several advantages over the more conventional FRET'. The distance at which 50l of the energy is transferred (R~) is large, 70A; the donor lifetime is single exponential and long (0.63msec in H20; 2.Smsec in D20), making lifetime measurements facile and highly accurate; the orientation dependence (x2) of energy transfer is minimized by the donor's multiple electronic transitions and long lifetime, limiting uncertainty in the measured distance due to orientation effects to +/-129& in the worst case'; the sensitized emission of the acceptor can be measured with little or no interfering background, yielding a >50 fold improvement in signal to background over standard donor-acceptor pairs and enabling distances several times R" to be measured'. We also measure the sensitized emission lifetime which, in our case, is independent of total concentration and incomplete labeling.
We have used both terbiums and europium as donors, and the results for europium are presented here. A schematic diagram of the donor-acceptor model system comprising double stranded DNA with europium chelate (donor) at one 5' end and CY-5 at other 5' end is shown below:

~~~7J~i WO 961011901 PCT/US95f08319 The europium chelate, (diethylenetriaminepentacetic acid-carbostyril 124-Eu: trivial name, DTFA-cs124-Eu) was made by a modification of the procedure of BaileytZ, starting with the dianhydride of DTFA (Sigma), carbostyril 124 (Aldrich), and the synthetic DNA base-protected and on the column to ensure that labelling occurs only at the 5' amino group. The cs124 effectively increases the absorption cross section of the europium to approximately $000 M-'cru' at 337nm, where we excited the donor with a pulsed Nitrogen laser. A 100-fold excess of EDTA did not remove any noticeable amount of europium from the DTPA-cs124 chelator.
The acceptor was 5' labeled with CY-5'3 (Biological Detection Systems) via standard methods. Unlabelled complementary DNA oligomers were made as controls. All DNA was reversed-phase HPLC purified. In this system, the double-stranded DNA oligomer serves as a rigid tether to establish a defined distance between the europium donor and the CY5 acceptor. The points of attachment of the donor and acceptor are separated by 42A, although the dye positions retain limited variability duo to the flexible six-carbon linkers used for attachment °'' Figure 3 shows the spectral characteristics which lead to the unusually large Ro of 70A in Dz0 (56A in Hz0). Ro is determined from standard equations) based on a calculated spectral overlap (J) of b.55 x10'3 Manm', an orientation factor (rcz) of 2/3, an index of refraction of 1.33, and a quantum yield for europium luminescence in DZO of one (0.25 in FI20)~. In calculating Ro it is important to use the quantum yield of the lanthanide emission, and not the quantum yield of the entire chelate, and to include in the spectral overlap (J) calculation only those PC1'IUS95108319 ~O 96100901 2$
transitions which are electric dipole. The europium emission at 6I7nm, which is used here for energy transfer, has been shown to be "forced" electric dipole9, and hence Fiirster's theory of energy transfer is applicable. The europium emission at 596nm cannot crouple to an acceptor because it is a magnetic dipole transition and so is not included in the spectral overlap calculation'°.
We can measure the sensitized emission of the acceptor without significant interference from either donor emission or direct acceptor fluorescence. At 668nm, europium is nearly silent (europium emission at 668nm is 125 times less than at its 617nm maximum) and by using pulsed-excitation and gating off the IO detector for 90msec, the direct fluorescence of the carbostyril sensitizer in the donor complex and the direct fluorescence of the CY-5 are completely eliminated, while the europium stays excited and capable of energy transfer".
Figure 4A shows such a dark-background sensitized emission experiment.
Here the ratio of donor to acceptor strands is approximately I:0.6; we intentionally add less acceptor than donor to show the ability of our system to analyze heterogeneous signals. The average fraction of energy transfer in figure 4A is 57~. The signal at 668 nm arises from sensitized emission of CY-5, i.e.
fluorescence due only to energy transfer. We calculate the signal/background at 668 nm to be 94:1 (where background is due to a small amount of europium luminescence), a factor of 50-100 improvement in signal/background over the sensitized emission signal from fluorescein-rhodamine, one of the best donor-acceptor pairs, attached to the same lOmer.
Figure 4B shows lifetime data corresponding to Figure 4A. The donor-only signal is single exponential with a lifetime of 2.52msec. The donor quenching signal fits a biexponent extremely well (r~=0.998): y = 633'oexp(-t/0.22msec) +
37 roexp(-t/2.40msec). The long-time component corresponds to the donor-only species. That the long-time component nearly equals the donor-only lifetime is an internal control which shows that intermolecular energy transfer is at most 5%.
The short time component arises from intramolecular energy transfer in the hybridized donor-acceptor complex and corresponds to 9I % quenching (1-0.22msec/2.52msec), and a donor-acceptor distance of 46A. (Fluorescein-rhodamine on the same DNA with C-6 linkers yields 2286 energy transfer'.) A
titration with increasing acceptor concentration increases the fraction of the short WO 96/00901 ~ ~ ~ ~~. ~ ~ Pt:TIU595/08319 time-component but does not change its lifetime, as expected. At two-fold excess of acceptor strand, a 10% camponent corresponding to donor-only signal remains, presumably due to unhybridized donor strands.
Figure 4B also shows the lifetime of the sensitized emission. The sensitized emission lifetime signal is fit to a biexponential (rz=0.999): y = 40%exp(-t159psec) + 60%exp(-t10.25msec). The short-time component is due to direct fluorescence of the acceptor and can be eliminated by gating the detector. The 0.25msec component is due to an energy transfer of 90 % (1-0.2512.52msec), in excellent agreement with the short-time component of the donor quenching. A
very small long-time component ( =1 %) can be seen due to direct donor fluorescence.
In summary, luminescence energy transfer yields results consistent with a FBrster theory assuming the appropriate parameters are used. Based on the large Ro, the ease and reproducibility of our lifetime measurements, and the excellent signal to background, distances significantly greater than 100A are measurable.
FOOTNOTED REFERENCES IN EXAMPLE 2.
(1) Cantor and Schimmel, (1980) Blophysieal Chemistry, W. H. Freeman and Co., San Francisco, Vol. 2; (2) Lanthanides in energy transfer have been used in diffusion enhanced FRET (Stryer, L., Thomas, D. D., Meares, C. F. (1982) In Annual Review of Biophysics and Bioengineering, L. J. Mullins, Ed., Annual Reviews, Inc., Palo Alto, CA, 11:203-222). They have also used been used with multichromophoric AlIophycocanin (Mathis, (1993) Clln. Chem. 39:1953) and as isomorphous replacements in calcium-binding proteins (Horrocks et al., Proc.
Nat.
Acad. Sci. USA (1975), 72:4764; Cronce and Horrocks, (1992) Biochem. 31:7963);
(3) Stryer, (1978) Ann. Rev. Binchcn:. 47:819-846; (4) The ability to measure energy transfer beyond Ro using sensitized emission has been shown by Bruno and Horrocks. They used terbium as the acceptor and tyrosine as the donor. With an Ro of 3A they measured out to 12A. (Bruno et al., (1992) Biachem. 31:7016);
(5) Selvin and Hearst, (1994) Proc. Natl. Acad. Sci, USA (submitted), (6) Cardullo et al., (1988) Proc. Natl. Acad. Sci., USA 85:8780; (7) Clegg et al., (1993) Proc.
Natl. Acad. Scl. USA 90:2994; (8) The exact quantum yield is difficult to determine although the long-lifetime and lack of radiationless deactivation mechanisms make it likely that the quantum yield is close to one in D20. This PGTIUS95l08319 assumption has given distances in agreement with x-ray crystallography studies (See ref 4). In HZO, the quantum yield is decreased because there are 1.3 water molecules in the primary coordination sphere of the lanthanide in our chelate (Horrocks and Sudnick, (1979) J. Am. Chem. Soc. 101:334); (9) Bunzli, J.-C.G.
5 (1989) In Lanthanide Probes in Life, Chemical and Earth Sciences, Theory oral Practice Luminescent Probes; BunzIi, J.-C.G. 8c Choppin, G.R. Ed., Elsevier, New York, pp. 219-293; (IO) Dexter, (1953) J. Chem. Phvs. 21:836; (11) Morrison has used gated integration to increase the signal to background of the sensitized emission with organic dyes. Morrison, (1988) Anal. Biochem.
174:101;
10 (12) Bailey et al., (i984) Analyst 109:1449; and (13) Mujumdar et al., (1993) Bloconf. Chem. 4:105.
Example 3. Terbium chelate -ftuorescein energy transfer.
This example employed a terbium chelate (Terbium-diethylenetriamine-15 pentaacetic acid coupled to carbostyril 124) transferring energy to fluorescein. The donor and acceptor are separated by an 8 mer DNA duplex oligonucleotide modified with a primary amine on the 5' end. The acceptor is attached to the S' end of a complementary oligonucleotide. The sensitized emission is measured with no background at around 520 nm. Furthermore, there is excellent overlap between 20 492 nm donor emission line and fluorescein absorbance, leading to a large Rfl. By using a pulsed excitation source and monitoring at 520 nm, any signal arises only from sensitized emission. The 8-mer oligonucleotide is used to rigidly separate the donor and acceptor, and the complex is immersed in a viscous sucrose solution to eliminate intermolecular interactions, though the sucrose solution is generally not 25 necessary when the oligonucleotide concentration is maintained below about 0.25 uM. Sensitized emission signal to background ratio at 520 nm is approximately 400:1. The extent of energy transfer based on both donor intensity quenching and the integrated sensitized emission area is 70%. Measurements of the unquenched donor lifetime (I.5 msec) in the absence of acceptor, and the sensitized emission 30 lifetime in the donor-acceptor complex (lifetime 250 usec), indicate a quenching of 85 ~ . The difference between the 70 and 85 °~ is due to the small fraction of unhybridized donor labeled DNA which cannot transfer energy.

w0 96100901 ~ C~1 ~ ~ ~ ~ PCTlUS95108319 Example 4. Assay for Enzymatic (1'roteolytic) Activity Fluorescence resonance energy transfer (FRET) has been used to study enzymatic activity where the distance between two labeled points changes as a function of this activity. In general, where FRET has been used, LRET can also be used, often with significant improvements. For example, Matayoshi et al.
(1990) Science 247:954-958, used FRET to measure HIV protease activity by labeling a substrate peptide with a donor and acceptor on either side of a protease bindinglcutting site. Because of the close proximity of the donor and acceptor, the donor fluorescence in the intact peptide was highly quenched. Upon addition of a protease, the peptide was cleaved, the donor and acceptor diffuse away from each other and the donor fluorescence increased approximately forty fold. The sensitivity of the assay is largely determined by the extent of donor quenching in the intact peptide. The lack of 100% quenching causes background fluorescence even in the absence of proteolytic activity. The authors note that they used a donor with a relatively long lifetime (tens of nanoseconds) because this helps increase donor quenching of the intact peptide. ('fhe reason is that the peptide is flexible and a long-lifetime allows the peptide time to flex such that the donor and acceptor come close together, resulting in donor quenching.) Replacing a standard fluorescent donor with a lanthanide chelate provides significantly reduced background, and hence, better sensitivity. The lanthanide chelate has a lifetime which is > 105 times longer than organic fluorophore, which leads to greater donor quenching due to the peptide flexibility. In addition, any residual donor luminescence can be discriminated against by using pulsed excitation and turning of the detector for some fraction of a millisecond after the pulse. If the donor is quenched by 9010 in the intact peptide, for example, the remaining 10% luminescence will have a lifetime 1/10 of the unquenched chelate, or approximately 100 usec. By gating off the detector for a few hundred microseconds, this residual donor luminescence is prevented from reaching the detector, while the unquenched luminescence which arises after proteolysis, which has approximately a millisecond lifetime, is relatively unaffected by the gating.
Lastly, the exceptional efficiency of energy transfer from the lanthanide chelates to acceptors allows the attachment points of the donor and acceptor to be placed W09610090I ~ ~ f~ ~ ~ ~ ~ PCI'IUS95l0$319 farther apart on the peptide than is possible with standard dyes. This is an important consideration when the binding site of the enzyme is large.
Example 5. Detection of genes and DNA sequences FRET has been used to detect specific DNA sequences, Morrison et al.
(1.989) Analytical Biochemistry 183:231-244, and Lee et al. (1993] Nucleic Acids Research 21:3761-3766. The primary advantage of using FRET in this application is that the technique is potentially sensitive (i.e. capable of detecting one or a few "target" DNA sequences), and can be done in a homogenous format. The same technique described by Lee et al. is now a commercially available product from Applied Biosystems known as "Taq-Man". In this application, a DNA probe complementary to the target DNA sequence is made with donor and acceptor attached. When the probe is intact and single-stranded, the donor is highly quenched because the acceptor is in close proximity. When the probe hybridizes to the target DNA, the probe is degraded by a specific endo or exonuclease. The donor is then free to diffuse away from the acceptor molecule, and donor fluorescence increases. If there is no target DNA, no specific degradation occurs and no specific increase in donor fluorescence occurs.
This system can also exploit amplification: there are many probe DNA
molecules and each 6me one binds, the probe in the double stranded product is hydrolyzed by the nuclease, and fluorescence increases. As soon as one probe molecule is degraded, another probe molecule can bind and the enzyme repeats the process. Hence, for only one target, the fluorescence from many probe molecules can be generated. A variety of exonucleases and endonucleases are compatible ZS with amplification; for example, Applied Biosystems utilizes Taq-palymerase, which has a 5' exonuclease activity. If the probe comprises RNA, RNAaseH may be used to exploit amplification.
In any of these FRET-based systems for DNA detection, replacing the organic dye donor with a lanthanide chelate improves the assay. The extent of donor quenching in the intact single-stranded probe is considerably greater because of the lanthanide's long-lifetime and efficient energy transfer. Any residual donor luminescence can he discriminated against with time-gating. The result is WO48/00401 ~ ~ t" '~ ~ ~ ~ PCTIUS451083t9 significantly decreased background (exactly analogous to the protease experiment outlined above).
Example 6. Lifetime-tailored Dyes As discussed above, the lanthanides can be used as luminescent labels in microscopy and detection in general. 13y using pulsed excitation and time-delayed detection, the lanthanide's long excited-state lifetime (milliseconds) enables signal to be isolated from background fluorescence, which tends to be of nanosecond duration. The long-lifetime, however, has the drawback that the signal intensity per molecule is necessary weak: a molecule with an excited state lifetime of 1 msec can emit at most 1,000 photonslsec. This is particularly significant at high illumination intensities, where the slow-emitting molecule may saturate. At low illumination intensity, the long lifetime is not deleterious because any one lanthanide is being excited at a rate less than the inverse of the lifetime.
Ideally, one would have a luminescent label in which the lifetime can be tailored to the optimal time-scale - long enough that background can be discriminated against, short enough that signal intensity is not significantly compromised. Since the background tends to have nanosecond lifetime, a probe with a microsecond lifetime, for example, would still have a thousand-times longer lifetime, enabling time-discrimination of the signal, but would potentially be able to emit 1,000 times more photonslsec than the millisecond lanthanide. Such lifetime-tailored dyes can be made by utilizing luminescence energy transfer between a Imthanide chelate (as donor) and a fluorescent acceptor. The signal will be the emission of the acceptor due to energy transfer. The lifetime of this emission (r) will equal the lifetime of the quenched donor and will be:
r = ra (1- E} (1) where ra is the lifetime of the lanthanide chelate in the absence of acceptor and E
is the fraction of energy transferred (also called the efficiency of energy transferred). The distance between the donor and acceptor (R) to achieve a given r can easily be calculated using the standard formula for FRET, Cantor et a1.
(19$0) Biophysical Chemistry, WH Freeman and Co, SF, a formula which has been shown to be applicable to LRET (Selvin et a1. (1994) PNAS USA 91:10024-10028;

wo ~sroosot ~ ~ ~ 3 5 ~ ~ rcr~tls~s~oa3is Selvin et al. J. Amer. Chem. Soc. 116:6029-6030; 5elvin et al. (1994) Methods in Enzymology, K Sauer, ed., Academic Press, Orlando):
E = 1I[1+(RIR~a] (2) where Ro can be calculated from the spectral properties of the donor and acceptor.
Combining equations 1 and 2 yields the lifetime as a function of distance between donor and acceptor:
r = ro I[I+(Ra/R)d] (3) if ro is 1.5 cosec, then with 909b energy transfer, the sensitized emission will decay with a lifetime of I~0 usec. With 99% energy transfer, the lifetime is 1S
uses. If a luminescent label with a lifetime of IS usec is desired, then the donor and acceptor should be placed such that 99~a energy transfer occurs. This corresponds to a distance of 0.465 x Ro. For Tb-chelate as donor, and tetramethylrhodamine as acceptor (Selvin, et al. 1995, supra), where Ra = 60A, this corresponds to 2$A.
A probe with a 1.5 uses lifetime can be achieved by placing donor and acceptor 0.316 Ra apart for 99.9°k energy transfer, or 19A for Tb-chelate and tetramethylrhodamine.
Note that lifetime-tailored dyes can be made to emit at many different colors. Any acceptor which can take energy from the luminescent lanthanide chelate are possible. The acceptor absorption need not overlap with the main emission line of the lanthanide; overlap with less intense emission lines can still yield very efficient energy transfer so long as the acceptor is placed sufficiently close. A donor/acceptor pair with an Ro of only 30A will still give 99.9 energy transfer at a distance of 9.SA. Further note that efficient energy transfer can arise even if the donor lanthanide has a relatively poor quantum yield for emission.
While Tb and Eu quantum yields tend to be fairly high in the appropriate chelate, other lanthanides and transition elements with significantly lower quantum yields, such as Pr, Nd, Sm, Dy, Ho, Er, Tm and Ru, Os, and Sm become useful donors as well. Finally, note that because the efficiency of energy transfer will in general be high (>90%) almost every photon which would have been emitted from the lanthanide, now gets emitted by the acceptor, but in a shorter period of time.
The only significant loss in photons arises from the non-unity quantum yield of the acceptor. This can be minimized by choosing acceptors with high quantum yields.

A wide variety of different linker molecules may be used to create thtse lifetime-tailored dyes. Generally, the subject linkers provide separation distances from about 4 to 60, preferably from about 9 to about 30A. The composition of the linker is selected based on the needs of the application, e.g. hydrophobic polymeric 5 linkers may be used to provide membrane permeable dyes. Peptides are readily synthesized to useful lengths, and their N- and C-termini can be used to attach the donor and acceptor. By introducing an internal aminophenylalanine (or a lysine), a reactive isothiocyanate is generated for attachment of the complex to a biological (or other) macromolecule. Peptides also have the advantage that the properties of 10 the peptide can be optimized for a particular application; for example, polyproline is very rigid and hydrophobic; polylysine is hydrophilic and highly positively charged; while polyglutamate or polyaspartate are hydrophilic and negatively charged. Other linkers include polymers such as polysaccharides, which have excellent solubility and reactivity, polyimides, and nucleic acids. The polymers 15 may be derivitized to provide improved attachment sites, e.g. a primary amine can be inserted into a nucleic acid strand and converted to an isothiocyanate group for attachment to macromolecules.
Although the foregoing invention has been described in some detail by way of illustration and example for purposes of clarity of understanding, it will be readily apparent to those of ordinary skill in the art in light of the teachings of this invention that certain changes and modifications may be made thereto without departing from the spirit or scope of the appended claims.

Claims (21)

WHAT IS CLAIMED IS:
1. A lanthanide chelate comprising a lanthanide chelator covalently joined to a sensitizer, wherein said chelate is capable of binding a lanthanide with an equilibrium constant of at least 10 6 M-1, a complex of said chelate and said lanthanide is capable of enhanced lanthanide luminescence, and said sensitizer comprises a polynuclear heterocyclic aromatic compound of the general formula:
wherein X comprises an atom from periodic group 5 or 6, wherein a single position 2-8 carbon atom of said sensitizer is substituted with a linking group through which said sensitizer is covalently joined to said chelator.
2. A chelate according to claim 1, wherein a first position 2-8 carbon atom of said sensitizer is substituted with an oxygen atom through a double covalent bond, and a second position 2-8 carbon atom of said sensitizer, different than said first position 2-8 carbon atom, is substituted with a linking group through which said sensitizer is covalently joined to said chelator.
3. A chelate according to claim 2, wherein said linking group consists essentially of an amine or carboxyl group.
4. A chelate according to claim 2, wherein said first position 2-8 carbon atom is the position 2 or 4 carbon atom and said second carbon atom is the position 7 carbon atom.
5. A chelate according to claim 2, wherein a third position 2-8 carbon atom of said sensitizer, different from said first and second position 2-8 carbon atoms, is substituted.
6. A chelate according to claim 5, wherein said third position 2-8 carbon atom is the position 4 carbon and is substituted with a hydrocarbon or halogen substituted hydrocarbon.
7. A chelate according to claim 1, wherein said sensitizer comprises a 2- or 4-quinolone or a 2- or 4- coumarin.
8. A chelate according to claim 1, wherein said sensitizer comprises carbostyril 124 (7-amino-4-methyl-2-quinolone), coumarin 120 (7-amino-4-methyl-2-coumarin), coumarin 124 (7-amino-4-(trifluoromethyl)-2- coumarin), aminomethyltrimethylpsoralen.
9. A chelate according to claim 1, wherein a complex of said chelate and a lanthanide capable of binding said chelate with an equilibrium constant of at least 109 M-1 is capable of at least ten fold greater luminescence probability than is said lanthanide.
10. A chelate according to claim 1, wherein a first solution comprising complexes of said chelate and a lanthanide capable of binding said chelate with an equilibrium constant of at least 10 9 M-1 is capable of at least ten fold greater luminescence than is a second solution comprising said lanthanide, wherein said first and second solutions are identical except for the presence of said chelate in said first solution and absence of said chelate in said second solution.
11. A chelate according to claim 1, wherein said lanthanide is terbium or europium.
12. A chelate according to claim 1, wherein said chelator is capable of binding said lanthanide with an equilibrium constant of at least 10 10 M-1.
13. A chelate according to claim 1, wherein said chelator comprises a plurality of carboxylate or phosphonate groups.
14. A chelate according to claim 1, wherein said chelator comprises DTPA.
15. A chelate according to claim 1, wherein said chelate is covalently joined to a macromolecule.
16. A molecular label comprising a chelate according to claim 1 covalently joined to a analyte-selective reagent.
17. A method of enhancing the luminescence of a lanthanide, said method comprising: forming a mixture of a lanthanide chelate according to claim 1 and a lanthanide capable of binding said chelate with an equilibrium constant of at least 10 9 M-1, whereby a luminescent lanthanide chelate-lanthanide complex is formed.
18. A chelate according to claim 1, wherein said enhanced lanthanide luminescence is at least 50,000% greater intensity.
19. A method of detecting an analyte which may be present in a portion of a sample by luminescence, said method comprising the steps of:
contacting a sample portion with a luminescent complex of a lanthanide chelate according to claim 1 and a lanthanide capable of binding said chelate with an equilibrium constant of at least 10 9 M-1, wherein said chelate is covalently joined to a reagent capable of selectively binding said analyte;
incubating said sample portion under conditions wherein said reagent is capable of selectively binding said analyte;
exposing said sample portion to light at a first wavelength capable of inducing a first electronic transition in said chelate;
detecting an emission of light from said sample portion at a second wavelength, wherein said second wavelength is longer than said first wavelength and results from a second electronic transition in said chelate;
wherein the detection of said emission of light correlates with the presence of said analyte sample portion.
20. A method of detecting the distance between a first position and a second position in a portion of a sample by resonance energy transfer using a luminescent lanthanide chelate donor and an organic resonance energy acceptor, said method comprising the steps of:
exposing a sample portion comprising said donor located at said first position and said acceptor located at said second position to light at a first wavelength capable of inducing a first electronic transition in said donor, wherein said donor comprises a complex of a lanthanide chelate according to claim 1 and a lanthanide capable of binding said chelate with an equilibrium constant of at least 10 9 M-1, and wherein the spectral overlap of the donor emission and acceptor absorption is sufficient to enable energy transfer from said donor to said acceptor as measured by detectable quenching of donor luminescence intensity or lifetime or detectable increase in acceptor luminescence intensity or lifetime;
detecting at least one of:
the intensity of a first emission of light from said sample portion at a second wavelength, wherein said second wavelength is longer than said first wavelength and results from a second electronic transition in said donor, wherein the intensity of said first emission of light inversely correlates with the distance between said first and second positions of said sample portion; and the intensity of a second emission of light from said sample portion at a third wavelength, wherein said third wavelength is longer than said first wavelength and results from an electronic transition in said acceptor, wherein the intensity of said second emission of light correlates with the distance between said first and second postions of said sample portion.
21. A method according to claim 20 used to monitor the status of a polymerase chain reaction, wherein, said sample portion comprises a target nucleic acid strand comprising a first strand portion and a diagnostic nucleic acid strand comprising a first atom covalently joined to said donor and a second atom covalently joined to said acceptor, said first and second atoms being separated by a second strand portion, wherein said first and second strand portions are sufficiently complementary to hybridize under annealing conditions; said second strand portion is of sufficient length to provide a detectable difference in the aggregate energy transfer from said donor to said acceptor when said first and second strand portions are hybridized as compared with the aggregate energy transfer from said donor to said acceptor when said first and second strand portions are not hybridized, wherein said detectable difference is measured as at least one of a detectable quenching of donor luminescence or detectable increase in acceptor luminescence, and said distance between said first and second atoms indicates whether said nucleic acid strands have hybridized.
CA002193501A 1994-06-29 1995-06-29 Luminescent lanthanide chelates and methods of use Expired - Lifetime CA2193501C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/269,162 US5622821A (en) 1994-06-29 1994-06-29 Luminescent lanthanide chelates and methods of use
US08/269,162 1994-06-29
PCT/US1995/008319 WO1996000901A1 (en) 1994-06-29 1995-06-29 Luminescent lanthanide chelates and methods of use

Publications (2)

Publication Number Publication Date
CA2193501A1 CA2193501A1 (en) 1996-01-11
CA2193501C true CA2193501C (en) 2000-08-08

Family

ID=23026062

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002193501A Expired - Lifetime CA2193501C (en) 1994-06-29 1995-06-29 Luminescent lanthanide chelates and methods of use

Country Status (8)

Country Link
US (3) US5622821A (en)
EP (1) EP0767912B1 (en)
JP (1) JP3814291B2 (en)
AU (1) AU688928B2 (en)
CA (1) CA2193501C (en)
DE (1) DE69535554T2 (en)
ES (1) ES2290953T3 (en)
WO (1) WO1996000901A1 (en)

Families Citing this family (145)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7081226B1 (en) 1996-06-04 2006-07-25 University Of Utah Research Foundation System and method for fluorescence monitoring
US7273749B1 (en) 1990-06-04 2007-09-25 University Of Utah Research Foundation Container for carrying out and monitoring biological processes
US5605798A (en) 1993-01-07 1997-02-25 Sequenom, Inc. DNA diagnostic based on mass spectrometry
US5925517A (en) * 1993-11-12 1999-07-20 The Public Health Research Institute Of The City Of New York, Inc. Detectably labeled dual conformation oligonucleotide probes, assays and kits
US5620850A (en) 1994-09-26 1997-04-15 President And Fellows Of Harvard College Molecular recognition at surfaces derivatized with self-assembled monolayers
US6770261B2 (en) * 1995-06-02 2004-08-03 Research Corporation Technologies Magnetic resonance imaging agents for the detection of physiological agents
WO1997033000A1 (en) * 1996-03-04 1997-09-12 Genetrace Systems, Inc. Methods of screening nucleic acids using mass spectrometry
US5928955A (en) * 1996-03-22 1999-07-27 California Institute Of Technology Peptidyl fluorescent chemosensor for divalent zinc
CA2252048C (en) * 1996-04-12 2008-03-11 The Public Health Research Institute Of The City Of New York, Inc. Detection probes, kits and assays
AU2735797A (en) * 1996-04-12 1998-03-26 Public Health Research Institute Of The City Of New York, Inc., The Detection probes, kits and assays
ES2434258T3 (en) * 1996-06-04 2013-12-16 University Of Utah Research Foundation Apparatus for carrying out PCR and monitoring the reaction in real time during temperature cycles
CA2591550C (en) 1996-06-04 2009-04-28 University Of Utah Research Foundation Monitoring hybridization during pcr
US5900228A (en) 1996-07-31 1999-05-04 California Institute Of Technology Bifunctional detection agents having a polymer covalently linked to an MRI agent and an optical dye
FI963989A (en) * 1996-10-04 1998-04-05 Wallac Oy Homogeneous methods of determination based on the transmission of luminescence energy
US7014992B1 (en) 1996-11-05 2006-03-21 Clinical Micro Sensors, Inc. Conductive oligomers attached to electrodes and nucleoside analogs
US20030129589A1 (en) * 1996-11-06 2003-07-10 Hubert Koster Dna diagnostics based on mass spectrometry
US6027709A (en) * 1997-01-10 2000-02-22 Li-Cor Inc. Fluorescent cyanine dyes
US6306584B1 (en) * 1997-01-21 2001-10-23 President And Fellows Of Harvard College Electronic-property probing of biological molecules at surfaces
WO1998039654A2 (en) * 1997-03-03 1998-09-11 Akzo Nobel N.V. Diagnostic neodymium(iii), ytterbium(iii), or erbium(iii) ion-ligand complexes
US6951760B2 (en) 1997-03-03 2005-10-04 Johannes Willem Hofstraat Diagnostic neodymium(III), ytterbium(III), or erbium(III) ion-ligand complexes
US7745142B2 (en) * 1997-09-15 2010-06-29 Molecular Devices Corporation Molecular modification assays
US20050227294A1 (en) * 1997-09-15 2005-10-13 Molecular Devices Corporation Molecular modification assays involving lipids
US7632651B2 (en) * 1997-09-15 2009-12-15 Mds Analytical Technologies (Us) Inc. Molecular modification assays
FR2768817B1 (en) * 1997-09-19 1999-12-10 Cis Bio Int HOMOGENEOUS METHOD FOR THE DETECTION AND/OR DETERMINATION OF THE PHOSPHORYLATING ACTIVITY OF A BIOLOGICAL MATERIAL
US6297018B1 (en) 1998-04-17 2001-10-02 Ljl Biosystems, Inc. Methods and apparatus for detecting nucleic acid polymorphisms
US6133429A (en) 1997-10-03 2000-10-17 Becton Dickinson And Company Chromophores useful for the preparation of novel tandem conjugates
US6713046B1 (en) 1997-10-27 2004-03-30 Research Corporation Technologies Magnetic resonance imaging agents for the delivery of therapeutic agents
EP1032430A2 (en) 1997-11-17 2000-09-06 Research Corporation Technologies, Inc. Magnetic resonance imaging agents for the detection of physiological agents
EP1057020A2 (en) * 1998-02-14 2000-12-06 GMD Forschungszentrum Informationstechnik GmbH Chemical activation mediated by the transfer of fluorescent energy for elucidating the 3-d structure of biological macromolecules
US6749811B2 (en) * 1998-04-28 2004-06-15 The Johns Hopkins University Molecularly imprinted polymer solution anion sensor
US7416703B2 (en) * 1998-04-28 2008-08-26 The Johns Hopkins University Polymer based lanthanide luminescent sensors for the detection of organophosphorus compounds
GB9811483D0 (en) * 1998-05-29 1998-07-29 Photonic Research Systems Limi Luminescence assay using cyclical excitation wavelength sequence
US6030840A (en) * 1998-06-15 2000-02-29 Nen Life Sciences, Inc. Neutral enhancement of lanthanides for time resolved fluorescence
US7087148B1 (en) 1998-06-23 2006-08-08 Clinical Micro Sensors, Inc. Binding acceleration techniques for the detection of analytes
GB9813776D0 (en) * 1998-06-25 1998-08-26 Smithkline Beecham Plc Novel compounds
US6740756B1 (en) 1998-07-07 2004-05-25 Smithkline Beecham Corporation Fluorescent lanthanide chelates
EP1095011A4 (en) * 1998-07-07 2003-01-08 Smithkline Beecham Corp Novel fluorescent lanthanide chelates
US5998146A (en) * 1998-07-17 1999-12-07 Wallac Oy Homogeneous luminescence assay method based on energy transfer
US6037130A (en) * 1998-07-28 2000-03-14 The Public Health Institute Of The City Of New York, Inc. Wavelength-shifting probes and primers and their use in assays and kits
US6740518B1 (en) 1998-09-17 2004-05-25 Clinical Micro Sensors, Inc. Signal detection techniques for the detection of analytes
DE19964220C2 (en) 1998-11-23 2003-07-03 Friz Biochem Gmbh Modified nucleic acid oligomer, useful for sequencing by hybridization, is substituted by redox agent to allow electrical detection of hybridization
AU2477000A (en) * 1998-12-11 2000-06-26 Pall Corporation Detection of biomaterial
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
DE19901761A1 (en) * 1999-01-18 1999-07-01 Gerhard Dr Hartwich Oligonucleotides tagged with photoinducible redox-active unit
FR2788523B1 (en) * 1999-01-18 2001-02-16 Commissariat Energie Atomique CALIXARENE DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR USE FOR THE EXTRACTION OF ACTINIDES AND LANTHANIDES
US6515113B2 (en) * 1999-02-18 2003-02-04 The Regents Of The University Of California Phthalamide lanthanide complexes for use as luminescent markers
US6838292B1 (en) * 1999-04-19 2005-01-04 Alion Science And Technology Corporation Detection of biological warfare agents
US20020177135A1 (en) * 1999-07-27 2002-11-28 Doung Hau H. Devices and methods for biochip multiplexing
US7312087B2 (en) 2000-01-11 2007-12-25 Clinical Micro Sensors, Inc. Devices and methods for biochip multiplexing
AT407876B (en) 1999-04-30 2001-07-25 Georg Dr Uray LUMINESCENT 4-TRIFLUORMETHYL-2-CHINOLINONES WITH LONG-WAVE UV ABSORPTION AND THEIR USE
US6410255B1 (en) * 1999-05-05 2002-06-25 Aurora Biosciences Corporation Optical probes and assays
US6402986B1 (en) 1999-07-16 2002-06-11 The Trustees Of Boston University Compositions and methods for luminescence lifetime comparison
US6667179B1 (en) * 1999-10-28 2003-12-23 The Board Of Trustees Of The University Of Illinois Semiconductor luminescence quenchers for detecting proximal molecular binding events
US7332344B2 (en) * 1999-12-01 2008-02-19 Photonic Research Systems Limited Luminescence assays
US20020072625A1 (en) * 1999-12-10 2002-06-13 Johnson David Kenneth Materials and methods for measuring chelate: anti-chelate binding by fluorescence polarization immunoassay
AU2001238011A1 (en) * 2000-01-31 2001-08-07 Board Of Regents, The University Of Texas System System for transferring fluid samples through a sensor array
EP1271133B1 (en) * 2000-02-28 2008-05-28 Daiichi Pure Chemicals Co., Ltd. Method of measurement based on fluorescence energy transfer using a long-lived fluorescence donor
US6528318B1 (en) * 2000-03-06 2003-03-04 The Johns Hopkins University Scatter controlled emission for optical taggants and chemical sensors
US20040146463A1 (en) * 2000-05-04 2004-07-29 Meade Thomas J. Functional MRI agents for cancer imaging
US6673333B1 (en) 2000-05-04 2004-01-06 Research Corporation Technologies, Inc. Functional MRI agents for cancer imaging
JP4382265B2 (en) * 2000-07-12 2009-12-09 日本電気株式会社 Method and apparatus for forming silicon oxide film
US6656450B2 (en) 2000-07-17 2003-12-02 California Institute Of Technology, Inc. Macrocyclic magnetic resonance imaging contrast agents
US6440389B1 (en) * 2000-07-19 2002-08-27 The General Hospital Corporation Fluorescent agents for real-time measurement of organ function
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US7029655B2 (en) 2000-10-04 2006-04-18 California Institute Of Technology Magnetic resonance imaging agents for in vivo labeling and detection of amyloid deposits
EP1337851B1 (en) * 2000-11-16 2005-07-20 Roche Diagnostics GmbH Dye pair for fluorescence resonance energy transfer (fret) measurements
US20030004236A1 (en) * 2001-04-20 2003-01-02 Meade Thomas J. Magnetic resonance imaging agents for detection and delivery of therapeutic agents and detection of physiological substances
US20020197648A1 (en) * 2001-05-02 2002-12-26 Silva Robin M. High throughput screening methods using magnetic resonance imaging agents
GB0113435D0 (en) * 2001-06-04 2001-07-25 Amersham Pharm Biotech Uk Ltd Acridone derivatives as labels for fluorescence detection of target materials
WO2003003063A2 (en) * 2001-06-28 2003-01-09 Ia, Inc. Fiber-optic sensor array
WO2003020701A2 (en) * 2001-09-04 2003-03-13 Texas Tech University Multi-use multimodal imaging chelates
DE10153829A1 (en) 2001-11-05 2003-05-28 Bayer Ag Assay based on doped nanoparticles
US7118871B2 (en) * 2002-04-22 2006-10-10 Lawler Joseph F Reagents for monitoring nucleic acid amplification and methods of using same
WO2004005917A1 (en) * 2002-07-08 2004-01-15 Daiichi Pure Chemicals Co., Ltd. Fluorescent probe
JP4206381B2 (en) * 2002-10-16 2009-01-07 哲雄 長野 Reagent for peroxynitrite measurement
US7696245B2 (en) * 2003-03-28 2010-04-13 Sekisui Medical Co., Ltd. Fluorescent probe for zinc
CA2445420A1 (en) * 2003-07-29 2005-01-29 Invitrogen Corporation Kinase and phosphatase assays
US7727752B2 (en) * 2003-07-29 2010-06-01 Life Technologies Corporation Kinase and phosphatase assays
US7619059B2 (en) * 2003-07-29 2009-11-17 Life Technologies Corporation Bimolecular optical probes
WO2005014796A2 (en) 2003-08-08 2005-02-17 Invitrogen Corporation Methods and compositions for seamless cloning of nucleic acid molecules
JP2007505315A (en) * 2003-09-12 2007-03-08 インヴィトロジェン コーポレーション Multiple binding and activity assays
CN1886661B (en) * 2003-10-01 2010-06-02 沃拉克有限公司 Improved homogeneous time-resolved energy transfer assay
EP1697534B1 (en) 2003-12-01 2010-06-02 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
JP2005194244A (en) * 2004-01-09 2005-07-21 Shigenobu Yano Zinc ion fluorescence sensor
CN1969181A (en) * 2004-04-08 2007-05-23 约翰霍普金斯大学 Processable molecularly imprinted polymers
WO2006039505A2 (en) 2004-09-30 2006-04-13 Molecular Devices Corporation Luminescent lanthanide complexes
US20060147954A1 (en) * 2004-10-19 2006-07-06 Wallac Oy Novel probe and its use in bioaffinity assays
DE112005002636T5 (en) * 2004-10-22 2007-09-06 Wallac Oy Highly sensitive homogeneous analysis based on FRET measurement with anti-Stokes shift
US20060171845A1 (en) * 2005-01-31 2006-08-03 Dakota Technologies, Inc. Sensors for measuring analytes
DK1885817T3 (en) * 2005-05-11 2016-08-22 Univ Durham Luminescent lanthanide OF RESPONSE
WO2007044091A2 (en) * 2005-06-02 2007-04-19 Fluidigm Corporation Analysis using microfluidic partitioning devices
US20070264678A1 (en) 2005-10-28 2007-11-15 Invitrogen Corporation Kinase and ubiquination assays
US8110404B2 (en) * 2005-11-14 2012-02-07 Board Of Trustees Of The University Of Illinois Luminescent lanthanide binding chelates
CA2660572C (en) * 2006-08-11 2014-07-22 University Of Medicine And Dentistry Of New Jersey Dual-sensitizer-containing luminescent compounds, conjugates, and uses thereof
WO2008064016A2 (en) * 2006-11-13 2008-05-29 Perkinelmer Las, Inc. Detecting molecular interactions
WO2008124834A1 (en) * 2007-04-10 2008-10-16 Stanford University Photoacoustic probes and methods of imaging
GB0805608D0 (en) * 2008-03-28 2008-04-30 Sec Dep For Environment Food & Detection method
US8889839B2 (en) * 2008-05-07 2014-11-18 Syracuse University Pyridine-bis (oxazoline)(“pybox”) moiety as a chelator and sensitizer for lanthanide ion (Ln (III)) Luminescence
FR2934684B1 (en) 2008-07-31 2012-11-16 Cis Bio Int METHOD OF DETECTING INTERNALIZATION OF MEMBRANE PROTEINS.
US7857900B2 (en) * 2008-09-19 2010-12-28 Xerox Corporation Solid phase change fluorescent ink and ink sets
DE102009000813A1 (en) 2009-02-12 2010-08-19 Evonik Degussa Gmbh Fluorescence conversion solar cell I Production by the plate casting method
FI20090100A0 (en) 2009-03-16 2009-03-16 Wallac Oy Biotinidaasimääritys
DE102009002386A1 (en) 2009-04-15 2010-10-21 Evonik Degussa Gmbh Fluorescence Conversion Solar Cell - Injection Molding Production
WO2010125314A1 (en) 2009-04-30 2010-11-04 Cis-Bio International Method for detecting compounds modulating dimers of vft domain membrane proteins
DE102009027431A1 (en) 2009-07-02 2011-01-05 Evonik Degussa Gmbh Fluorescence conversion solar cell - Production by extrusion or coextrusion
FR2949156B1 (en) 2009-08-13 2016-04-15 Cis-Bio Int METHOD FOR DETERMINING THE BINDING OF A COMPOUND GIVEN TO A MEMBRANE RECEPTOR
GB0915986D0 (en) 2009-09-14 2009-10-28 Sec Dep For Environment Food A Detection method
BR112012008381A2 (en) 2009-09-24 2017-06-13 Inserm (Institut Nat De La Santé Et De La Rech Médicale) fkbp52-tau interaction as a new therapeutic target to treat neurological disorders involving tau dysfunction
KR101684838B1 (en) 2009-10-28 2016-12-08 휴렛-팩커드 디벨롭먼트 컴퍼니, 엘.피. Single-layer reflective display utilizing luminescence
US9221759B2 (en) * 2010-01-13 2015-12-29 Rutgers, The State University Of New Jersey Fluorophore chelated lanthanide luminescent probes with improved quantum efficiency
DE102010028180A1 (en) 2010-04-26 2011-10-27 Evonik Röhm Gmbh Plastic molding useful for manufacturing solar panels, comprises polymethyl(meth)acrylate coated with a film made of several individual layers, which are dyed with a fluorescent dye
DE102010028186A1 (en) 2010-04-26 2011-10-27 Evonik Röhm Gmbh Plastic molded body made from a transparent, thermoplastic polymer, useful in an arrangement for producing a collector of solar cell, comprises coatings, which are colored with fluorescent dye, and are applied by roll coating method
DE102010038685A1 (en) 2010-07-30 2012-02-02 Evonik Röhm Gmbh Fluorescence Conversion Solar Cell Manufactured by plate casting
WO2012017194A1 (en) * 2010-07-31 2012-02-09 Advanced Biomedical Limited Method, reagent, and apparatus for detecting a chemical chelator
US8778614B2 (en) 2010-08-24 2014-07-15 Enzo Life Sciences, Inc. Assays for detecting modified compounds
GB201018361D0 (en) 2010-11-01 2010-12-15 Thompson Edward J Fluorometry
DE102011001368B4 (en) * 2011-03-17 2013-01-31 Bundesanstalt für Materialforschung und -Prüfung (BAM) Lanthanoid chelates containing particles, their preparation and their use in bioanalysis
FR2977674B1 (en) 2011-07-06 2015-08-14 Cisbio Bioassays IMPROVED METHOD OF DETECTING AND / OR QUANTIFYING AN ANALYTE PRESENT AT THE SURFACE OF A CELL
FR2978149B1 (en) 2011-07-18 2014-01-10 Cisbio Bioassays NOVEL COMPLEXING AGENTS AND COMPLEXES OF CORRESPONDING LANTHANIDE, AND THEIR USE AS LUMINESCENT MARKERS
FR2980271B1 (en) 2011-09-16 2013-10-11 Cisbio Bioassays METHOD FOR DETERMINING GLYCOSYLATION OF ANTIBODY
EP2817614A1 (en) 2012-02-22 2014-12-31 Cisbio Bioassays Method for normalising the luminescence emitted by a measuring medium
FR2988174B1 (en) 2012-03-19 2014-04-25 Cisbio Bioassays METHOD FOR DETERMINING THE CAPACITY OF ANTIBODY TO MAINTAIN CELLS CLOSE TO EACH OTHER
WO2013177206A2 (en) 2012-05-21 2013-11-28 Fluidigm Corporation Single-particle analysis of particle populations
AU2013277946B2 (en) 2012-06-22 2018-07-12 Macquarie University Multiplex suspension assay/array using lifetime coding
US20150276760A1 (en) 2012-10-04 2015-10-01 INSERM (Institut National de la Sante Et de la Recherche Medicate) Method for Screening a Compound Capable of Inhibiting the Notch1 Transcriptional Activity
FR3000960B1 (en) 2013-01-16 2015-03-06 Cisbio Bioassays NOVEL WATER SOLUBLE COMPLEXING AGENTS AND CORRESPONDING LANTHANIDE COMPLEXES
WO2014136115A1 (en) 2013-03-07 2014-09-12 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Non-selfabsorbing luminescent solar concentrator
FR3004189B1 (en) 2013-04-04 2015-09-04 Ecole Norm Superieure Lyon LANTHANIDE COMPLEXES COMPRISING AT LEAST TWO BETA GROUPS, USEFUL AS LUMINESCENT MARKERS
DE102013113348B4 (en) * 2013-12-02 2017-04-13 Karlheinz Mayer Device for measuring DNA quantum states and use thereof
US20170051062A1 (en) 2014-02-18 2017-02-23 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods and Pharmaceutical Compositions for the Treatment of Diseases Mediated by the NRP-1/OBR Complex Signaling Pathway
US10189887B2 (en) 2014-04-17 2019-01-29 Inserm (Institut National De La Sante Et De La Recherche Medicale) Polypeptides and uses thereof for reducing CD95-mediated cell motility
FR3032797B1 (en) 2015-02-13 2017-03-03 Cisbio Bioassays METHOD OF QUANTIFYING A PROTEIN OF INTEREST PRESENT IN A BIOLOGICAL SAMPLE
US10989665B2 (en) * 2015-06-17 2021-04-27 Total Sa Method and solution for assaying inhibitors in a petroleum fluid containing water
EP3314255B1 (en) 2015-06-25 2019-07-31 H. Hoffnabb-La Roche Ag Cell based assay for determining antibody or ligand binding and function
FR3045053B1 (en) 2015-12-09 2018-01-05 Cisbio Bioassays TRIAZAPYRIDINOPHANE WATER-SOLUBLE COMPLEXING AGENTS AND CORRESPONDING FLUORESCENT LANTHANIDE COMPLEXES
US11738321B2 (en) * 2016-06-02 2023-08-29 The Regents Of The University Of California Lanthanide-chelator combinatorial barcoding
JP7215999B2 (en) 2016-12-21 2023-01-31 エフ.ホフマン-ラ ロシュ アーゲー Assays for Determining Antibody or Ligand Binding and Function
FR3067349B1 (en) 2017-06-12 2020-12-04 Cisbio Bioassays NEW MONO AND DI-ANTENNAS WATER-SOLUBLE COMPLEXANTS AND CORRESPONDING LANTHANIDE COMPLEXES
FR3067712B1 (en) 2017-06-14 2019-08-02 Cisbio Bioassays NOVEL HYDROSOLUBLE TRIMETHOXYPHENYL PYRIDINE-LIKE COMPLEXANTS AND CORRESPONDING LANTHANIDE COMPLEXES
FR3069644A1 (en) 2017-07-28 2019-02-01 Cisbio Bioassays METHOD FOR MEASURING MODULATION OF G PROTEIN-COUPLED RECEPTOR ACTIVATION
US11214795B2 (en) * 2017-09-25 2022-01-04 California Institute Of Technology Bistable polynucleotide devices for the sensing and quantification of molecular events
FR3084365B1 (en) 2018-07-27 2020-10-23 Cisbio Bioassays SINGLE DOMAIN ANTIBODIES BOUND WITH G ALPHA PROTEIN
WO2020144324A1 (en) 2019-01-11 2020-07-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods for screening inhibitors against chikungunya virus and for determining whether subjects are predisposed to infection by said virus
FR3092172B1 (en) 2019-01-30 2021-02-12 Cisbio Bioassays Method for measuring the modulation of activation of a G protein coupled receptor with GTP analogues
TW202334089A (en) 2021-11-02 2023-09-01 美商夫雷爾醫療公司 Pparg inverse agonists and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4637988A (en) * 1981-07-01 1987-01-20 Eastman Kodak Company Fluorescent labels for immunoassay
US4837169A (en) * 1981-07-01 1989-06-06 Eastman Kodak Company Polypyridine Fluorescent labels for immunoassay
US4421654A (en) * 1981-07-01 1983-12-20 Dow Corning Corporation Metal extraction from solution and novel compounds used therefor
US4794191A (en) * 1981-07-01 1988-12-27 Eastman Kodak Company Fluorescent chelates
US4801722A (en) * 1981-07-01 1989-01-31 Eastman Kodak Company Coumarin chelates
US5021567A (en) * 1987-09-24 1991-06-04 Abbott Laboratories 8-hydroxyquinoline chelating agents
SE8801702D0 (en) * 1988-05-05 1988-05-05 Pharmacia Ab SET FOR DETERMINATION OF ENZYMATIC ACTIVITY

Also Published As

Publication number Publication date
EP0767912B1 (en) 2007-08-08
JPH10505820A (en) 1998-06-09
DE69535554T2 (en) 2008-04-30
ES2290953T3 (en) 2008-02-16
WO1996000901A1 (en) 1996-01-11
AU2956795A (en) 1996-01-25
JP3814291B2 (en) 2006-08-23
EP0767912A4 (en) 2001-08-22
CA2193501A1 (en) 1996-01-11
US5656433A (en) 1997-08-12
AU688928B2 (en) 1998-03-19
DE69535554D1 (en) 2007-09-20
US5622821A (en) 1997-04-22
EP0767912A1 (en) 1997-04-16
US5639615A (en) 1997-06-17

Similar Documents

Publication Publication Date Title
CA2193501C (en) Luminescent lanthanide chelates and methods of use
EP0174744B1 (en) Fluorescent energy transfer with phycobiliproteins
US5756011A (en) Detecting or quantifying multiple analytes using labelling techniques
Soini et al. Fluoroimmunoassay: present status and key problems.
EP0580979B1 (en) Method of detection by inducing electrochemiluminescence
Sun et al. Advances in the study of luminescence probes for proteins
US5486616A (en) Method for labeling and detecting materials employing arylsulfonate cyanine dyes
EP0478626B1 (en) Detecting or quantifying multiple analytes using labelling techniques
Hicks Fluorescence immunoassay
JP2001502055A (en) Homogeneous luminescence energy transfer assay
SE454115B (en) HOMOGENIC PHASE ANALYSIS WITH LANTANIDE KELAT AS BRAND SUBSTANCE
WO1988004777A1 (en) Monomeric phthalocyanine reagents
JPH0137694B2 (en)
US5019496A (en) Photopolymerization diagnostic test composition and method for immunoassay and nucleic acid assay
Deshpande Principles and applications of luminescence spectroscopy
Ozinskas et al. Homogeneous model immunoassay of thyroxine by phase-modulation fluorescence spectroscopy
Seitz et al. Fluorescence derivatization
Barbarakis et al. Enhancement of the emission intensity of fluorophore-labeled avidin by biotin and biotin derivatives. Evaluation of different fluorophores for improved sensitivity
US5314802A (en) Light emission- or absorbance-based binding assays
US5017475A (en) Fluorescent detection method based on enzyme activated conversion of a fluorophore precursor substrate
Höfelschweiger The pyrylium dyes: a new class of biolabels. Synthesis, spectroscopy, and application as labels and in general protein assay
Kokko et al. Particulate and soluble Eu (III)-chelates as donor labels in homogeneous fluorescence resonance energy transfer based immunoassay
US6951760B2 (en) Diagnostic neodymium(III), ytterbium(III), or erbium(III) ion-ligand complexes
Hoefelschweiger et al. Screening scheme based on measurement of fluorescence lifetime in the nanosecond domain
Savitsky et al. Solid surface measurement of room temperature phosphorescence of Pd-coproporphyrin and its application for time-resolved microscopy

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20150629